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ABSTRACT
EFFECTS OF PERMETHRIN, A PYRETHROID INSECTICIDE, ON GLUCOSE AND
LIPID METABOLISM
MAY 2017
XIAO XIAO, B.S., HUNAN AGRICULTURAL UNIVERSITY, CHINA
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Yeonhwa Park
Over the last few decades, the decline of using organochlorine and
organophosphorus insecticides has partially contributed to the rising utilization of newer
synthetic insecticides, which are considered as less harmful and more environmental
friendly than the older generation of insecticides. Pyrethroid insecticides are one of the
newer insecticide classes reported with better biodegradability and low mammalian
toxicity without sacrificing its insecticidal efficacy. Permethrin is one of the most widely
used pyrethroid insecticides with structural similarity with natural pyrethrin insecticide
from the flowers of Chrysanthemum cinerariifolium. Since its introduction in the 1970’s,
permethrin has been extensively used in medicine, military, household, industry and
agriculture. Although a large body of evidence have supported that exposure to
organochlorine and organophosphorus insecticides could increase the risk of developing
obesity and diabetes, less attention has been drawn to pyrethroids. It has been reported
recently that permethrin potentiated adipogenesis and insulin resistance in vitro. This
study is designed to determine the effects of exposure to permethrin, along with the
interaction with high-fat diet, on glucose and lipid metabolism in vivo. Our results
demonstrated that chronic exposure to low level of permethrin could disturb glucose and
lipid metabolisms in female and male mice in a diet-dependent manner. Exposure to
vi

permethrin significantly increased insulin resistance in male and female mice fed high-fat
diet as demonstrated by impaired insulin sensitivity, glucose tolerance and increased
HOMA-IR. Permethrin treatment also significantly increased weight gain and adipose
tissue weight in high-fat fed male mice but not female mice. Further mechanistic studies
in mice showed that permethrin can target AMPK pathway, AKT pathway, and fatty acid
oxidation to influence glucose and lipid metabolisms. In vivo studies in 3T3-L1
adipocytes showed that permethrin potentiated adipogenesis via calcium- and
endoplasmic reticulum (ER) stress- mediated mechanisms. The current results suggest
that exposure to permethrin can potentially disturb glucose and lipid metabolisms
resulting in increased risk of developing obesity and type 2 diabetes.

Key words: Pyrethroids, permethrin, obesity, type 2 diabetes, adipogenesis, insulin
resistance.
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CHAPTER 1
INTRODUCTION
Obesity is associated with energy imbalance with increased energy intake and
reduced energy expenditure. Western diet, sedentary lifestyle, genetic defects and
socioeconomic status have been widely accepted as the contributing factors linked with
the pathogenesis of obesity. Type 2 diabetes are often associated with obesity, marked by
elevated blood glucose level and insulin resistance 1. More recently, a growing body of
evidence has suggested that exposure to environmental pollutants, including insecticides,
are linked with increased risk of obesity and type 2 diabetes 2-13. Along with our
continuing efforts to find bioactive food compounds to fight against obesity and diabetes,
searching the contributing factors of these diseases can create new opportunities to
protect the health and wellness of human beings.
Permethrin [(±)-3-Phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2dimethylcyclopropanecarboxylate] is one of the synthetic pyrethroid insecticides
structurally based on the natural pyrethrins. First synthesized in 1973 and marketed in
1977, permethrin exhibits environmental stability and excellent potency against a wide
spectrum of insect pests, while retaining a large margin of mammalian safety 14-16.
The insecticidal mechanism of action of permethrin relies on its ability to elicit a
rapid functional disruption in the neuromuscular system by membrane depolarization.
Permethrin is known to slow the inactivation of voltage sensitive sodium channel
(VSSC), a pore forming transmembrane protein that consists of four homologous
domains (I-IV) 14, 17, 18.
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In mammals, permethrin can be quickly biotransformed by ester cleavage and
oxidation reactions and almost completely eliminated via urinary and fecal excretions
within 12 days 16. In the environment, permethrin can be degraded and disappeared
rapidly (several hours to 58 days) by photolysis, microbial and plant biotranformations 16.
Based on these characteristics, permethrin became the first pyrethroid to be used
to protect agricultural crops, public and animal health in the US 15, 18. In the US alone,
~2.2 million lbs of permethrin have been sprayed annually to agricultural plots,
residential areas and specific sites important to public health. Approximately 63% of this
amount of permethrin is applied to residential areas 19. Permethrin has been formulated in
pet products and veterinary medications to control ectoparasitic arthropod pests,
including over-the-counter formulations to control human head lice 20, 21. Additionally,
many biting arthropods show avoidance behaviors to permethrin, hence many permethrin
treated materials (e.g., permethrin impregnated clothing including military uniforms, pet
collars, and mosquito nets) have been developed and used to repel blood feeding
arthropods 22. The wide-spread use of those pyrethroids suggests that human exposure to
permethrin is quite likely.
Previously, permethrin was reported to promote adipogenesis and induce insulin
resistance in cell culture models similar to other types of insecticides 23-26; however, there
is a lack of in vivo study determining the effect of permethrin on glucose and lipid
metabolisms. In addition, the molecular mechanisms regarding how permethrin
potentiated adipogenesis and insulin resistance in vitro have not been fully explored.
Thus, the purpose of this study was to investigate the effects of permethrin exposure on
development of dietary-fat-induced obesity and type 2 diabetes in both female and male

2

mice. The molecular mechanisms of permethrin-potentiated adipogenesis in 3T3-L1
adipocytes were also studied.
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CHAPTER 2
LITERATURE REVIEW

2.1 Insecticide introduction and classification

Insecticides, which are mostly neurotoxins, are a group of substances used to kill
insect pests that are harmful to humans, crops, livestock, and pets 27. The use of
insecticides can be dated back to ancient civilization. The Sumerians used sulphur
compounds against insects and mites around 4,500 years ago and the Chinese used
arsenical compounds and mercury to control body lice about 3,200 years ago 28. In the
20th century, the rise of modern synthetic chemistry and the demand for more food has
contributed to the rising use and syntheses of numerous organic insecticides 29.
Insecticides can be classified based primarily on their chemical structures and
mode of actions. Major classes of insecticides include organochlorines,
organophosphorus, carbamates, pyrethroids, and neonicotinoids. Organochlorine
insecticides were introduced in the 1940s, followed by organophosphorus insecticides
(1950s), carbamates (1960s), pyrethroids (1970s), and neonicotinoids (1990s) 27. A few
examples of each type are shown in Table 2.1.
Table 2.1. Major classes of insecticides with examples
Organochlorines
Aldrin
DDT/DDE
Dieldrin
Heptachlor
Lindane
Methoxychlor

Organophosphorus
Chlorpyrifos
Diazinon
Dichlorvos
Malathion
Parathion
Profenofos

Carbamates
Aldicarb
Bendiocard
Carbaryl
Dioxacarb
Fenobucarb
Isoprocarb
Methomyl
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Pyrethroids
Allethrin
Bifenthrin
Cismethrin
Cyhalothrin
Deltamethrin
Permethrin
Tefluthrin

Neonicotinoids
Acetamiprid
Clothanidin
Dinotefuran
Imidacloprid
Niternpyram
Thiacloprid
Thiamethoxam

Most of the organochlorine insecticides are extremely lipophilic and chemically
stable 30. Organochlorine insecticides can be divided into dichlorodiphenyltrichloroethane
(DDT)-type and chlorinated alicyclic-type (cyclodienes) based on their distinctive
mechanisms of action. DDT-type insecticides (such as DDT and dicofol) are known to
inhibit the closing of voltage-sensitive sodium channel (VSSC) in neurons, resulting in
repetitive firing of action potentials, while chlorinated alicyclic-type insecticides (e.g.
aldrin, dieldrin, heptachlor, and endosulfan) bind to γ-aminobutyric acid (GABA)
chloride ionophore complex, which inhibits chloride influx into the nerve 30, 31. DDT was
once the most popular insecticide used in the 1940s to 1960s to reduce insect-born
disease, such as malaria, yellow fever, and typhus, because of its broad-spectrum activity
against insects and its relatively low mammal toxicity 32, 33. DDE, also used as an
insecticide, is the major biological metabolite and environmental breakdown product of
DDT. Due to their toxicity on wild bird populations and high stability in the environment,
most developed countries have banned the use of DDT and other chlorinated
hydrocarbons, including the United States in 1972. Certain developing countries are still
using organochlorines nowadays because of their effectiveness against certain diseasecarrying insects and insect resistance to other insecticides 34. Even though most countries
have not used organochlorines for the last several decades, due to extremely stable
chemical characteristics, DDE (as a major metabolite of DDT) can currently be found in
human serum, adipose tissue, and many foods 30, 35.
Organophosphorus insecticides are irreversible inhibitors of cholinesterases,
including acetyl cholinesterase, resulting in hyper-stimulation of cholinergic nerves (e.g.
muscarinic and nicotinic acetylcholine receptor) 36. As the largest insecticide class in the
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world in 1980s, organophosphorus insecticides occupied 71% of world insecticides
market in 1987; however, the use of organophosphorus insecticides dropped to around
52% in 1999 and to 13% in 2013 37-39. The use of organophosphorus insecticides was
decreased due to their environmental persistence and mammalian toxicity, although some
are considered as relatively less toxic to humans and less stable in the environment than
organochlorines 27, 40.
Carbamates, which account for 6% of global insecticides 39, have the similar
mechanism of action with organophosphorus insecticides, but their neurotoxic effects are
relatively more moderate than organophosphorus because the inhibition of acetyl
cholinesterase is reversible and carbamates are known to be rapidly metabolized by
human and animals 30, 41.
Developed in the 1960s and 1970s, pyrethroids are structural analogs to naturally
occurring insecticide, pyrethrin, found in Chrysanthemum flower heads. Pyrethroids can
cause over excitation of the neuron by delaying the closing of VSSC, producing an effect
similar to, but more pronounced than, DDT due to its better sodium channel binding
capacity 18, 34. Generally, pyrethroid can be divided into two types; Type I and Type II.
Type I pyrethroid (non -cyano moiety) mainly generates repetitive firing of action
potential, which leads to the tremor syndrome (T-syndrome). Type II pyrethroids (cyano moiety) cause excessive membrane depolarization that leads to decreased action
potential, which will eventually block nerve signal conduction, leading to choreoathetosis
with salivation (CS syndrome) 42, 43. By 2013, pyrethroids accounted for approximately
17% of the global insecticide market 39.
Neonicotinoids are a relatively new family of insecticides with structural
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resemblance to nicotine 27. Acting on nicotinic acetylcholine receptors, neonicotinoids
can stimulate these receptors at low doses, while blocking these receptors at high doses,
leading to paralysis and death 44. Their high affinity for insect nicotinic acetylcholine
receptors, but not to vertebrate nicotinic acetylcholine receptors, contributes to their
selective toxicological properties 45, 46. Ever since their first introduction in 1991,
neonicotinoids have become the fastest growing class of insecticides used in protection of
both agricultural crops and animal health, representing ~27% of the global insecticide
market in 2013, which makes them the largest single insecticide class on the market 39, 47.
Due to the potential link between use of neonicotinoids and the reduction of bee
population, the European Commission has banned use of three neonicotinoids
(imidaclorprid, thiamethoxam, and clothianidin) in 2013 48.

2.2 Glucose and lipid metabolism overview
Glucose, the most important carbohydrate as energy source, is utilized by various
organs and tissues after being absorbed into the blood stream to form ATP through
glycolysis and oxidative phosphorylation. On the other hand, dietary lipids such as
triglycerides (TG) and free fatty acids (FFAs) also play critical roles in energy
homeostasis. Fats are believed to provide even more energy per gram basis than glucose
through β-oxidation and citric acid cycle 49. The rise and fall of blood glucose and lipids
level generate signals to induce the secretion of a variety of hormones to maintain energy
homeostasis by controlling the storage of excessive energy in the fed state and
breakdown of intracellular energy source in the fasting state. Through this hormone-
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mediated mechanism, blood glucose and lipids (TG, FFAs, cholesterol etc.) are able to be
maintained in a normal range in healthy individuals 50.
Insulin is the central hormone regulating glucose and lipid metabolism in the fed
state. The rise of glucose and after meal generate signals to induce the secretion of insulin
from pancreas. Insulin promotes glucose uptake and glycogen synthesis in muscle and fat
while inhibiting glucose production from the liver by blocking glycogenolysis and
gluconeogenesis. Insulin also stimulates lipogenesis and protein synthesis while
inhibiting lipolysis and protein degradation. Skeletal muscle is the major target site for
insulin-dependent glucose disposal (up to 75%), while adipose tissue accounts for only a
small fraction 51, 52. Insulin does not stimulate glucose uptake in liver, instead, it blocks
glycogenolysis and gluconeogenesis while stimulating glycogen synthesis 52. Other
tissues not normally sensitive to insulin action such as brain and pancreatic β-cells are
also important in regulating glucose homeostasis 52-54. Thus, insulin resistance or
deficiency can result in severe dysregulation of glucose and lipid homeostasis manifested
by elevated fasting and postprandial glucose and lipids levels.

2.2.1 Insulin signaling pathways
Insulin initiates its action by binding to insulin receptors. Insulin receptors,
including insulin like growth factor (IGF)-I receptor and insulin receptor-related receptor
(IRR), are tyrosine kinases 55. Insulin can increase the kinase activity of the insulin
receptors, which subsequently phosphorylate insulin receptor substrates 56. Among them,
insulin receptor substrate (IRS)-1 is believed to play a major role in regulating insulin
signaling 57-59. Phosphorylated tyrosines in IRS serve as “docking sites” for proteins
containing SH2 (Src-homology-2) domains, including the p85 regulatory subunit of
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phosphoinositide 3-kinase (PI(3)K) and protein tyrosine phosphatase (SHP2). PI(3)K is
critical in regulation of insulin action. The activation of PI(3)K can stimulate the
phosphorylation of phosphoinositides to produce phosphatidylinositol-3-phosphates,
especially phosphatidylinositol (3,4,5)-triphosphate (PIP3), which then bind to
phosphoinositide-dependent kinase (PDK1). PDK1 belongs to the family of serine
kinases that phosphorylates the serine/threonine kinase Akt (protein Kinase B). Akt also
plays important role in transmission of insulin signal by controlling glucose transporter 4
(GLUT4) translocation and glycogen synthesis via phosphorylated inhibition of glycogen
synthase kinase-3 (GSK-3) 60. Atypical protein kinase Cs (PKCs), downstream of PI(3)K
during insulin stimulation, are also suggested to play an important role in GLUT4
translocation 61.
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Figure 2.1. Insulin signaling pathways. Akt, protein kinase B; C3G, rap guanine
nucleotide exchange factor 1; CAP, c-Cbl-associated protein; Cbl, casitas B-lineage
lymphoma; CrkII, proto-oncogene c-Crk II; IRS-1, insulin receptor substrate-1; GS,
glycogen synthase; GSK-3, glycogen synthase kinase-3; PDK1, phosphoinositidedependent kinase-1; PI3K, phosphatidylinositol-3-kinase; PIP3, phosphatidylinositol
(3,4,5)-trisphosphate; PKCλ/ζ, protein kinase C λ/ζ; PP1, protein phosphatase 1; PTEN,
phosphatase and tensin homolog; PTP1β, protein tyrosine phosphtase 1β; Ser, serine;
SHIP2, SH2 domain-containing inositol 5-phosphatase 2; SHP2, protein tyrosine
phosphtase 2;Tyr, tyrosine.
On the other hand, other intracellular signals may attenuate or block insulin
signaling. For example, in addition to tyrosine phosphorylation described above insulin
receptor and IRS proteins may undergo serine phosphorylation, which decrease insulin
signaling by attenuating insulin stimulated tyrosine phosphorylation 62. Protein tyrosine
phosphatases (PTPases) can also attenuate insulin signaling by rapid dephosphorylation
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of insulin receptor and its substrates. Among them, protein tyrosine phosphatase 1B
(PTP1B) are the most documented 63. Overexpression of phosphatidylinositol-3phosphates, such as phosphatase and tensin homologue (PTEN) and SH2 domaincontaining inositol-5-phosphtase (SHIP2), can decrease the level of PIP3, thus reduce
insulin sensitivity 64, 65.
In addition to PI(3)K activity, another pathway for insulin-stimulated glucose
uptake via GLUT4 translocation have been identified 66. Cbl (casitas B-lineage
lymphoma) is a ubiquitin ligase that can be tyrosine phosphorylated by insulin receptor.
Cbl is usually binding with c-Cbl-associated protein (CAP), an adapter protein, to form
Cbl-CAP complex. Upon phosphorylation, the Cbl-CAP complex can be translocated to
the lipid raft domains in the plasma membrane escorted by protein flotillin and adapter
molecule Crk II (also known as proto-oncogene c-Crk or p38, a protein that in humans is
encoded by the CRK gene) 67. Crk II can also form a complex with rap guanyl
nucleotide-exchange exchange factor 1 (C3G), which can subsequently activate G protein
TC10 in the proximity of lipid rafts. This provides a second signal for GLUT4
translocation in parallel with PI(3)K pathway 52, 68.

2.2.2 Regulation of glucose metabolism in liver
Glycogen content is tightly regulated by insulin and glucagon. Insulin stimulates
glycogen synthesis by activating glycogen synthase through the inhibition of kinases such
as protein kinase A (PKA) or glycogen synthase kinase 3 (GSK-3) and activating protein
phosphatase 1 (PP1) 52, 60, 69.
Gluconeogenesis and glycogenolysis is also tightly regulated by insulin. Insulin
directly controls the activities of a series of enzymes by phosphorylation and
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dephosphorylation cascades and mediate the gene expression encoding enzymes involved
in gluconeogenesis and glycolysis 70. Insulin inhibits the transcription of enzymes
involved in gluconeogenesis, including phosphoenolpyruvate carboxylase (PEPCK),
fructose-1,6-bisphosphatase, and glucose-6-phosphatase, 71 while increases the
transcription of glycolytic enzymes, including glucokinase and pyruvate kinase, and
lipogenic enzymes, such as fatty acid synthase (FAS) and acetyl-CoA carboxylase
(ACC). Forkhead family of transcription factors 72, peroxisome proliferator-activated
receptor gamma coactivator 1 (PGC-1) 73 and sterol regulatory element-binding
protein 1 (SREBP-1) 74 are suggested to control gene expression of enzymes involved in
insulin-regulated gluconeogenesis and glycogenolysis.
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Figure 2.2. Regulation of gluconeogenesis, glycogenolysis, glycolysis, glycogen
synthesis and lipid synthesis in the liver. ACC, acetyl-CoA carboxylase; AMPK, AMPactivated protein kinase; F-1,6-Pase, fructose-1,6-bisphosphatase; Fructose-6-P, fructose
6-phosphate; FAS, fatty acid synthase; HK, hexokinase; Glucose-6-P, glucose-6phosphate; G-6-Pase, glucose-6-phosphtase; Glut2, glucose transporter 2; GK,
glucokinase; GP, glycogen phosphorylase; GS, glycogen synthase; PDH, pyruvate
dehydrogenase; PEPCK, phosphoenolpyruvate carboxykinase; PFK,
phosphofructokinase; PGC1α, peroxisome proliferator-activated receptor gamma
coactivator 1-alpha; PGM, phosphoglucomutase; PK, pyruvate kinase; SREBP, sterol
regulatory element-binding protein.

2.2.3 Insulin resistance
Insulin resistance is considered as a pathological state in which there is reduced
responsiveness of circulating insulin 75. Insulin resistance in obesity and type 2 diabetes is
believed to be associated with many factors in insulin signaling, including decreased
concentration of insulin receptor and IRS, decreased tyrosine kinase activities of insulin
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receptor and IRS, activity of PI(3)K, glucose transporter translocation, and activities of
various intracellular enzymes 66.
In addition, adipose tissue may also contribute to insulin resistance by elevating
circulating FFAs, which may result in reduced glucose uptake, glycogen synthesis and
glucose oxidation yet stimulated hepatic glucose output 76. This process is believed to be
associated with reduction in IRS-1 and PI(3)K activities and accumulation of
triglycerides and fatty acid-derived metabolites (e.g. diacylglycerol, fatty acyl-CoA and
ceramides) in muscle and liver 52. A number of hormones secreted by fat cells,
collectively called adipokines, including TNF-α, leptin, adiponectin and resistin, are also
playing important roles in regulation of metabolism, energy expenditure and insulin
resistance 52, 62. Activation of PKC and/or inhibitor of nuclear factor κB (IκB) kinase and
serine phosphorylation of the insulin receptors and its substrates might be another
important mechanism 52.

2.2.4 Adipogenesis
When there is less energy expenditure than energy intake, most of the extra
energy is stored in adipocytes in the form of triglycerides. As a result, adipose tissue
mass arise by either increase in adipocyte cell size, cell number or both 50. Adipocyte size
is well correlated with the amount of stored triglycerides. It is suggested that mild obesity
is generally associated with increases in cell size (hypertrophic obesity), while more
severe obesity also involves increased fat cell number (hyperplastic obesity).
Adipogenesis can be generally divided into several parts: preadipose proliferation,
adipocytic differentiation, and lipogenesis. The molecular mechanism regulating
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adipogenesis has been extensively studied in recent years. The key regulators have been
identified as PPARɣ, the CCAAT-enhancer-binding proteins (C/EBP)s, and adipocyte
determination and differentiation-dependent factor 1 (ADD1)/SREBP1 50. In addition to
insulin, glucocorticoids, a steroid hormone secreted from adrenal gland, has also been
suggested to play a central role in regulating adipogenesis. In fact, it has been
demonstrated that the induction of PPARɣ gene by C/EBPβ,δ is largely dependent on the
presence of glucocorticoid 50, 77.

Figure 2.3. Regulation of adipogenesis. ADD1, adipocyte determination and
differentiation-dependent factor 1; CEBPα, CCAAT/enhancer-binding protein alpha;
CCAAT/enhancer-binding protein beta/delta CEBPβ/δ; PPARɣ, peroxisome proliferatoractivated receptor gamma; SREBP1c, sterol regulatory element-binding transcription
factor 1c.
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2.2.5 Regulation of lipogenesis and lipolysis
The lipogenesis and lipolysis in adipocytes are well regulated by both hormone
(e.g., insulin) and sympathetic stimulation (e.g., adrenergic) 70. In the fed state,
adipocytes can pick up glucose and store them primarily as lipid with the help of insulin
and lipogenic enzymes, including lipoprotein lipase, pyruvate dehydrogenase, fatty acid
synthase, and acetyl-CoA carboxylase. Insulin can inhibit lipolysis in adipocytes
primarily through inhibition of hormone-sensitive lipase via reduction in cAMP
concentration and PKA activation 78, 79.
In the fasting state or when energy expenditure is increased, adipocytes
breakdown triglycerides into free fatty acids and glycerol and release them into blood
stream for fatty acid oxidation in liver, muscle and brown adipose tissue (BAT). Unlike
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white adipose tissue, which is designed for storage of excess energy, BAT is designed for
energy expenditure by producing heat 50.

Figure 2.4. Regulation of lipogenesis and lipolysis in adipocyte. ACC, acetyl-CoA
carboxylase; AKT, protein kinase B; AMPK, AMP-activated protein kinase; cAMP,
cyclic adenosine monophosphate; CD36, cluster of differentiation 36;DGAT, diglyceride
acyltransferase; FAS, fatty acid synthase; FFA, free fatty acid; Glucose-3-P, glycerol-3phosphate; Glut4, glucose transporter 4; IRS, insulin receptor substrate; LPL, lipoprotein
lipase; HSL, hormone-sensitive lipase; PDE3B, phosphodiesterase 3B; PDH, pyruvate
dehydrogenase; PDK1, phosphoinositide-dependent kinase-1; PI3K,
phosphatidylinositol-3-kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PKA,
protein kinase A;TG, triglycerides; VLDL, very-low-density lipoprotein.
2.3 Effects of insecticide exposure on glucose and lipid metabolisms
2.3.1 Effects of insecticides on risk of diabetes in human
Numerous epidemiological studies have found a potential association between
insecticide exposure with increased risks of diabetes (summarized in Table 2.2). For this
table, we have included elevated fasting blood glucose levels and insulin resistance as
evidence of diabetes risk. Organochlorine and organophosphorus insecticides are the
most studied, but few others reported on the role of pyrethroids, carbamates and
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neonicotinoids on diabetes.
Most studies on organochlorines linked the blood levels of organochlorines or
their metabolites with increased risk of diabetes in humans, as these are known to be
persistent in human tissues, particularly fatty tissues. Overall, there is strong indication
that exposure to these insecticides leads to increased risk of diabetes. In addition, Boada
et al. 80 reported a negative correlation between blood levels of aldrin and p,p’-DDD and
insulin-like growth factor-1, which are also known to have implications for development
of insulin resistance 81.
Organophosphorus and carbamate insecticides have also been generally linked
with increased risk of diabetes in humans, including pesticide applicators who were
exposed to dichlorvos and trichlorfon 10. Interestingly, Saldana et al. reported that wives
of pesticide applicators of organophosphorus insecticides (diazinon and phorate) along
with carbamate insecticide (carbofuran) have increased risks of gestational diabetes
mellitus, while no association was found for other organophosphorus (malathion and
terbufos) or carbamate insecticide (carbaryl) 82. In addition, a study reported that patients
with acute organophosphorus poisoning due to suicide attempts had hyperglycemia 83.
Reports on the effects of pyrethroids on diabetes from human studies are rather
limited and no human study on neonicotinoids and diabetes is available currently. One
study reported that pyrethroid mixture increases the risk of diabetes among pesticide
factory workers in China

84

. Another study reported that exposure to pyrethroid

insecticides (allethrin and prallethrin) increased plasma glucose levels in Indian men 85.
Since neonicotinoids have been used in the last few decades and they are designed to be
relatively quickly degraded in biological systems, it is more challenging to investigate the
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exposure to neonicotinoids on human health perspectives 86. Overall, the majority of
human studies have shown a positive association between exposure to certain type of
insecticides and risk of diabetes.
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Table 2.2. Effects of insecticide exposure on risk of diabetes in human
Insecticidea

Risk of
diabetesc

Other
comments

Country

Subject

Reference

USA

Pesticide applicators

↑

10

USA

General population

↑

87

USA

Pesticides applicators

↑

10

South
Korea

Age ≥ 40

×

88

Sweden

Aged 50-74 years old

×

89

Sweden

Fishermen and their wives

↑

11

USA

General population

↑

87

USA

Native Americans

↑

2

USA

Mexican Americans

↑

90

Sweden

Fishermen’s wives

↑

91

USA

Non-diabetic

↑c

6

Canada

First Nation Community
members

↑

92

Sweden

50-59 years old

↑

93

USA

Great Lakes sport fish
consumer

↑

94

USA

General population

↑

95

USA

African and White
Americans

×

7

South
Korea

Age ≥ 40

↑

88

Slovakia

Polluted area

↑

96

Finland

57-70 years old

↑

97

Belgium

Hospital patients, staff and
volunteers

×

3

USA

Non-diabetic

↑d

8

Sweden

Age > 70

×

98

Denmark

General population

↑

99

Spain

General population

×

100

Spain

Hospital patients

↑

101

Organochlorine
Aldrin
Chlordane

p,p′-DDD

p,p′-DDE
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o,p'-DDE

p,p'-DDT

o,p′-DDT

↑ Blood DDE in
diabetic
individuals

Canada

First Nations community
members

×

Benin

18-65 years old

↑

103

Russia

8-9 years old boys

×d

104

Belgium

General population

↑

105

South
Korea

Hospital patients

↑

106

Slovakia

Polluted area

↑

107

Thailand

General population

↑

108

Saudi
Arabia

30-50 years old

↑

109

USA

Great Lake Sport fish
consumer

↑

110

Belgium

Aged 50-65 years old

↑

only in men

111

↓ Insulin &
adiponectin level
in female
newborns

112

102

France

Newborns

×

Canada

Pregnant women

×e

113

Denmark

General population

↑

99

USA

Mexican Americans

↑

90

USA

General population

↑

4

USA

Non-diabetic

×d

5

USA

General population

↑

95

USA

African and White
Americans

×

7

South
Korea

Age ≥ 40

↑

88

Slovakia

Polluted area

↑

96

USA

Non-diabetic

×d

8

Denmark

General population

↑

99

Spain

General population

×

100

Benin

18-65 years old

↑

103

Hospital patients

↑

106

30-50 years old

↑

109

Age ≥ 40

↑

88

South
Korea
Saudi
Arabia
South
Korea

21

Dieldrin

HCB

Denmark

General population

↑

99

USA

General population

×

95

Sweden

50-74 years old

↑

89

USA

Native Americans

↑

2

USA

Mexican Americans

×

90

USA

African and White
Americans

×

7

South
Korea

Age ≥ 40

↑

88

Slovakia

Polluted area

×

USA

Non-diabetic

×d

8

Sweden

Age > 70

×

98

Denmark

General population

↑

99

Spain

General population

↑

100

Spain

Hospital patients

×

101

Canada

First Nations community
members

×

Russia

8-9 years old boys

↑d

104

Slovakia

Polluted area

↑

107

> 40 years old

↑

114

Hospital patients

↑

106

Belgium

50-65 years old

↑

111

Canada

First Nations community
members

↑

102

South
Korea

Hospital patients

↑

106

Sweden

Fishermen and their wives

↑

USA

General population

↑

87

Sweden

50-74 years old

×

89

USA

Mexican Americans

↑

90

USA

Non-diabetic

×d

5

USA

Non-diabetic

×c

6

USA

General population

↑

95

South
Korea
South
Korea

cis-nonachlor

↑ only
prediabetes

↑ Blood HCB

only in men

96

102

11

CB-153

β-HCH

22

USA

African and White
Americans

×

7

South
Korea

Age ≥ 40

↑

88

Slovakia

Polluted area

×

Belgium

Hospital patients, staff and
volunteers

↑

3

USA

Non-diabetic

×d

8

Denmark

General population

×

99

Spain

General population

×

100

Spain

Hospital patients

↑

101

Canada

First Nations community
members

×

Benin

18-65 years old

↑

103

Saudi
Arabia

18-65 years old

↑

115

Russia

8-9 years old boys

×d

104

Aged > 40 years

↑

114

Hospital patients

×

106

USA

African and White
Americans

×

7

USA

Non-diabetic

×d

8

Saudi
Arabia

18-65 years old

↑

115

USA

Pesticide applicators

↑

10

USA

General population

↑

95

USA

General population

↑

116

South
Korea
South
Korea

Age ≥ 40

↑

88

Age > 40

↑

114

USA

Native Americans

↓

2

USA

General population

×

95

USA

African and White
Americans

↑

7

South
Korea

Age ≥ 40

↑

88

USA

Non-diabetic

×d

8

South
Korea
South
Korea
ɣ -HCH

Heptachlor
Heptachlor
epoxide (A
metabolite of
heptachlor)

Mirex

23

↑ only
prediabetes

↑ Blood β-HCH

96

102

Oxychlordane

TNC

↑ Blood mirex in
diabetic
individuals

Canada

First Nations community
members

×

Sweden

50-74 years old

×

89

USA

General population

↑

87

USA

Mexican Americans

↑

90

USA

Non-diabetic

↑d

5

USA

Non-diabetic

×c

6

USA

General population

↑

95

USA

African and White
Americans

×

7

South
Korea

Age ≥ 40

↑

88

Finland

57-70 years old

↑

97

USA

Non-diabetic

×d

8

Canada

First Nations community
members

↑

South
Korea

Aged > 40 years

↑

114

Canada

Pregnant women

×e

113

Sweden

50-74 years old

×

89

USA

General population

↑

87

USA

Mexican Americans

↑

90

USA

Non-diabetic

↑d

5

USA

Non-diabetic

×c

6

USA

General population

↑

95

USA

African and White
Americans

×

7

South
Korea

Age ≥ 40

↑

88

Finland

57-70 years old

↑

97

USA

Non-diabetic

×d

8

Sweden

age > 70

↑

98

Canada

First Nations community
members

↑

102

Benin

18-65 years old

↑

103

24

↑ Blood
oxychlordane in
diabetic
individuals

102

102

113

Pregnant women

×e

France

Newborns

×

Canada

Pregnant women

↓e

113

Canada

Pregnant women

↓e

113

Turkey

Overdose patients

↑c

Iran

Farmers

↑

India

A 15-year-old girl

↑c

Israel

Children

↑c

119

USA

Wives of pesticide
applicators

↑e

82

USA

Pesticides applicators

↑

10

81-year-old mother and her
39-year old son
Wives of pesticide
applicators

↑c

Canada
Organophosphorus
Dialkylphosphate
(Metabolites)
Dimethylphosphate
(Metabolites)
Dimethylthiophosphate
(Metabolites)

Mixture

Diazinon

Dichlorvos

Canada
Malathion

USA
Egypt

Phorate

USA

Terbufos

USA

Trichlorfon

USA

×e

↑ Insulin level

Case report

112

83
117

Case report

Case report

118

120
82

Non-diabetic male famers

↑

Wives of pesticide
applicators
Wives of pesticide
applicators

↑e

Pesticides applicators

↑

10

Wives of pesticide
applicators
Wives of pesticide
applicators

×e

82

↑e

82

×

121
82
82

Carbamates
Carbaryl

USA

Carbofuran

USA

Pyrethroids
Allethrin

India

Mosquito repellent coils or
mats users

↑c

85

Permethrin

USA

Pesticides applicators

×

10

Prallethrin

India

Mosquito repellent coils or
mats users

↑c

85

China

Pesticide factory workers

↑

84

Bolivia

Male pesticide sprayers

↑

122

Pyrethroid
mixture
Pyrethroid
mixture

25

Other insecticide
Amitraz

Turkey

↑c

Overdose patients

Case report

123

Mixture of
124
chlopyrifos &
Morocco A 30-year-old man
↑c
Case report
cypermethrin
a
Abbreviation for insecticides: 2,2′-bis (4-chlorophenyl)-1,1-dichlorodiethylene (p,p'- DDD), 2,2′-bis (4chlorophenyl)-1,1-dichloroethylene (p,p'- DDE); 2,2′-bis (4-chlorophenyl)-1,1,1-trichloro-ethane (p,p'DDT); Hexachlorobenzene (HCB); 2,2’,4,4’,5,5’-Hexachlorobiphenyl (CB-153); βHexachlorocyclohexane (β-HCH); ɣ-Hexachlorocyclohexane (ɣ-HCH); trans-nonachlor (TNC).
b
Abbreviation: ↑, increase; ×, no association with; Gestational diabetes mellitus (GDM). Risk of diabetes
including elevated blood glucose levelc, insulin resistanced, and gestational diabetes mellituse.

2.3.2 Effects of insecticides on body weight change in human
Compared to the large number of epidemiological studies on insecticide and
diabetes, a relatively small number of studies reported a link between insecticide
exposure and obesity (summarized in Table 3). Three reported positive association
between organochlorine exposure (DDE and β-hexachlorocyclohexane) and body mass
index (BMI) 3, 8, 9, while others found no association between organochlorine insecticide
exposure (including DDE and β-HCH) and BMI 3, 8, 9, 89.
For other markers of lipid metabolism, there were no effects of organochlorines
on high-density lipoprotein cholesterol (HDL-cholesterol), except one study reported
negative correlation between DDE and HDL 6. Others reported that pyrethroid
insecticides, allethrin and prallethrin, were linked with disturbed lipid metabolism by
increasing triglycerides, phospholipids, very low-density lipoprotein cholesterol (VLDLC), but no effects on HDL 85.
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Table 2.3. Effects of insecticide exposure on body weight change in human
Insecticidea

Study information
Country Description

BMI

Resultsb
Others

Reference

Organochlorine
Sweden

Women

USA

Non-diabetic

Belgium
USA
p,p’-DDE
Spain

Denmark
Slovakia
Belgium
p,p’-DDT

USA
Sweden
USA

Spain
HCB
Denmark

Obese and lean
men & women
African and
White
Americans
Women in early
pregnancy &
their newborn
children
General
Population

↑

↑

N/A

↑

Only in men

=

= TG
= HDL-C

Aged 50-65
years old
Women
Non-diabetic

↑

N/A

=
N/A

Obese and lean
men & women
African and
White
Americans
Women in early
pregnancy &
their newborn
children
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= TG
= HDL-C

↑
=

=

9

99
107
111

8

8

9

=

N/A

8

89

=

↑

Spain

↑ Weight in the first 6
months;
↑ BMI at 14 months in
infancy
↑ Lipid oxidation;
↑FFA
↑ TG & cholesterol; ↓
testosterone in males

Aged 50-65
years old
African and
White
Americans
Women
African and
White
Americans
Women in early
pregnancy &
their newborn
children
General
Population

Polluted area

USA

↑ TG
↓ HDL-C

↑

=

6
3

Polluted area

Slovakia

Belgium

= TG

=

30-50 years old

Sweden
USA

β-HCH

N/A

Saudi
Adults

Belgium

89

=

↑ Lipid oxidation
↑ TG; ↓ HDLcholesterol
↑ TG & cholesterol; ↓
testosterone in males
Only in women

99
115
107
111
89

= TG
↑ Waist &
subcutaneous
abdominal fat mass
= TG
= HDL-C

6

3

8

9

ɣ-HCH

USA
Sweden
USA

Oxychlordane
USA
Sweden
USA
TNC
USA

Mirex

USA

African and
White
Americans
Women
Non-diabetic
African and
White
Americans
Women
Non-diabetic
African and
White
Americans
African and
White
Americans

=
=
N/A
=
=
N/A

= TG
= HDL-C

8

89

↑ TG

6

↑ TG
= HDL-C

8

89

= TG

6

=

= TG
= HDL-C

8

=

= TG
= HDL-C

8

↑

↑ Waist circumference

Organophosphorus
Malathion

Egypt

Non-diabetic
male famers

121

Pyrethroids
↑ TG, phospholipids,
lipid peroxides, &
VLDL-C;
85
Allethrin
India
Men
N/A
↓ Cholesterol
&glycolipids;
= HDL-C & LDL-C
↑ TG, phospholipids,
lipid peroxides, &
VLDL-C;
85
Prallethrin
India
Men
N/A
↓ Cholesterol &
glycolipids;
= HDL-C & LDL-C
a
Abbreviation for insecticides: 2,2′-bis (4-chlorophenyl)-1,1-dichloroethylene (p,p'- DDE); 2,2′-bis (4chlorophenyl)-1,1,1-trichloro-ethane (p,p'- DDT); Hexachlorobenzene (HCB); β-Hexachlorocyclohexane
(β-HCH); ɣ-Hexachlorocyclohexane (ɣ-HCH); trans-nonachlor (TNC).
b
Abbreviation for results: ↑, increase; ↓, decrease; =, no change; BMI, body mass index; GDM, gestional
diabetes mellitus; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol; N/A, not available; TG, triglyceride; VLDL-C, very low-density lipoprotein cholesterol.

2.3.3 Effects of insecticides exposure on glucose and lipid metabolisms in animals
Although different classes of insecticides have slightly different mechanisms of
insecticidal action, many share common characteristics by acting on the nerve system.
Common symptoms after exposure to insecticides include spasm, muscular tremors, and
convulsions 27, 37. Overstimulation of the nervous system increases the energy demands
and disturbs the functions of several organs, resulting in the disorder of energy
28

homeostasis that can lead to altered glucose and lipid metabolisms 125-128.

2.3.3.1. Effects of insecticides on blood glucose level in rodents
Studies have shown that exposure to all major types of insecticides induced
hyperglycemia in experimental mice and/or rats (summarized in Table 2.4.). Among
them, organochlorine and organophosphorus compounds are the most documented with
relatively less reports on carbamates, pyrethroids, and neonicotinoids. Studies have
demonstrated that exposure to certain organochlorines, organophosphorus, pyrethroids,
and neonicotinoids elevated blood glucose levels, although inconsistent results have also
been reported (Table 2.4.). This inconsistency may derive from the difference in dose and
route of exposure, animal species, exposure duration, as well as methods to determine
insulin resistance 129. In fact, others suggested that insecticide-induced hyperglycemia is
only temporary: blood glucose concentration increased initially and then decreased with
the possibility of reaching hypoglycemia 129-131. More importantly, our group recently
reported that low doses of orally administrated permethrin or imidacloprid (levels lower
than NOAEL) potentiate insulin resistance, only when high-fat diet was provided in mice
132-134

. These results suggest that low dose insecticide exposure should be evaluated along

with other factors contributing to development of diabetes.

2.3.3.2. Effects of insecticides on body weight in rodents
Although it is known that overstimulation of the nervous system increases the
energy demands that are potentially linked to reduced weight, a number of studies
reported that exposure to insecticides can lead to increased body weight gain, while other
studies found inconsistent results (summarized in Table 2.4.) 125-128. Exposures to
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organochlorine insecticides (DDE, HCB, and ɣ-HCH) have led to increased body weight
gain in rodents (Table 2.4.) 135-138, including a study of parental trans-generational
exposure to DDT linked to increased obesity rate in the offspring 139. Similarly, others
reported that perinatal exposure to DDT was linked to significant weight gain, but only in
female offspring 140. Another study found reduced weight after dieldrin exposure 141.
Organophosphorus insecticides have also been demonstrated to have moderate
obesogenic effects. Chronic exposure to chlopyrifos under manifestation of cholinergic
toxicity was reported to increase body weight in mice and rats 142, 143, including
developmental exposure of chlorpyrifos on weight gain in male, but not female offspring
144

. Others reported reduced or no changes in weight after exposure to chlorpyrofos,

dichlorvos, or dimethoate 145-147.
Limited data are available for effects of pyrethroids and neonicotinoids on weight
gain. Exposure to cypermethrin (a pyrethroid) or imidacloprid (a neonicotinoid)
significantly decreased body weight in mice or rats 148-150, while no effects of
deltamethrin on weight in mice was reported 151. Recently, our group reported that low
doses of orally administrated permethrin or imidacloprid (levels of NOAEL and ADI)
potentiate weight gain in male mice only when high-fat diet was provided 133, 134. Taken
collectively, the effects of insecticide exposure on body weight change are rather limited
and inconsistent, likely depending on various factors, such as dose and route of
administration, species, sex, and treatment duration. With new reports on low doses of
insecticides and dietary fat interaction, it is possible that effects of insecticide exposure
will be significant, particularly for relatively long-term low-dose exposure, when
combined with other known contributing factors of obesity.
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Table 2.4. Effects of insecticides-induced alteration of glucose and lipid metabolism in mice and rats
Resultse

Treatment
Insecticide

Dose
(mg/kg a)

Routeb

Durationc

Oral

Daily for 5
d, tested
after 7, 14,
21 & 28d

Oral

Daily for
5d, 1 wk
rest, +13
wk HFD or
LFD w/o
DDE

Oral

Single,
tested after
0-18h & 7
d

Sexd

BW

Glucose

Insulin

M

↑ (2)

↑ (2; 7 &
21 d)

M

=

↑ in HFD
(wk 4 &
8)

N/A

↓ 5-7h,
↑ Baseline
glucose in
GTT after
7d

= (18h)

TG

Cholesterol

Other comments

Reference

Mice
Organochlorine

0.4 & 2

DDE
2

50

M

DDT
1.7

=

N/A

N/A

↓ in HFD

=

=

Oral

Daily for
16 d
(GND11.5PND5)

F&
pups

↓ in ♂
(PND5);
↑ in adult
♀

↓ (PND5);
= (6 m
postwean)

↑ in ♀ w/
HFD;
= (6 m
postwean)

Oral
(Diet)

8 wk

Mf

↑

↑

↑

= Glucagon;
= Insulin resistance;
= pAkt Ser473/Akt (liver,
muscle & fat);
= Leptin & resistin
= Leptin & resistin;
Muscle:
↑ Glut4 in HFD;
Fat:
= Glut4;
Liver:
↓ Lipogenesis in HFD;
↑ FA oxidation in HFD;
↑ FA uptake in HFD;
↓ Gluconeogenesis in HFD

135

152

N/A

↓ Glucose tolerance at 18h;
↓ Insulin secretion from
isolated islet of pancreas at
18h, but not at 7d

153

↑ in ♀ w/
HFD

↑ in ♀ w/
HFD;

↑ Insulin resistance in ♀ w/
HFD & ♂ w/ LFD;
↑ Fat mass in adult ♀;
= Lipid level (during 6 m of
post-weaning);
= Food intake;
= FFAs

140

=

↑

↑ Insulin resistance;
↑ Food intake;
↑ Leptin in ApoE3f

142

N/A

Organophosphorus

Chlorpyrifos

2

31

Diazinon

6.5
(1/10
LD50)

i.p.

5 times
weekly for
7 wk

M

N/A

↑

N/A

↑

↑

Tea and olive leaves extract
prevented diazinondisturbed glucose and lipid
metabolism

154

↑ Lipid content in serum,
liver & kidney;
↑ Phospholipid in serum,
liver, & kidney;
↓ Phospholipid in brain;
= FFAs;
↓ Lipase activity in liver and
serum

155

Carbamates

Furadan

0.125,
0.25, &
0.5

i.p.

Weekly for
2,4, & 6
wk

M

N/A

N/A

N/A

↑

↑

10

Oral

Daily for
28 d

M

↓

↓

N/A

↑

↑;
↑ VLDL, ↓
HDL

Pyrethroids
Cypermethrin

Deltamethrin

149

1&3
(1/4 of
NOAEL)

Oral
(Diet)

Every 3 d
in gestation
& lactation
in dams

F&♂
pups

= in ♂
pups

N/A

N/A

N/A

N/A

Gene expression in fat of ♂
pups:
↓ Glucose transport: Glut4
(1) & Glut2;
↓ Lipogenic gene (1)
: SREBP1, ACC-1, FABP4,
CD36, LPL & SCD-1;
↓ Adipogenesis (1): PPARɣ
& CEBPα

5,10, &15

Oral

Daily for
15 d

M

↓ (15)

N/A

N/A

N/A

N/A

↑ Liver & kidney weight
(15)

148

=

↑ Leptin; = FFA;
Fat:
↑ cell size; ↑ CD36,
SREBP1, TNFα;
↓ CaMKKβ,
pAMPKα/AMPKα,
pACC/ACC;
Liver:

134

151

Neonicotinoids

Imidacloprid
0.06, 0.6
&6

Oral

Daily for
12 wk

M

↑

↑

↑

32

↑

↑ PEPCK; ↓ CaMKKβ,
PPARα, pAMPKα/AMPKα,
pACC/ACC, Sirt1, PGC-1α;
Muscle:
↓ GLUT4; ↑ PDK4; = CPT1

Rat
Organochlorine

N/A

↓ in
sedentary
rats; ↑ in
exercised
rats;
Significant
interaction
DDT ×
Exercise

N/A

N/A

1

Oral
(Diet)

180 d

M

N/A

N/A;

↓ in
sedentary
rats;
Significan
t
interactio
n DDT ×
Exercise

20

Oral

Daily for
189 d

F

=

N/A

N/A

25 & 50

i.p.

Daily for 6
d (GND814)

F/M

↑ in F3

N/A

N/A

N/A

N/A

30

Oral

Single, test
after 24h

M

=

N/A

N/A

N/A

N/A

2

Oral

6m

M

↓

↑

N/A

N/A

=

F/M

↑ ♂ (40)
w/ food
deprivatio
n,
↑ in ♂ (20
& 100)
w/o food
deprivatio
n

DDT

Dieldrin

HCB

*20 &
100;
40 & 200
w/ food
deprivatio
n;

Oral
(Diet)

4 wk

N/A

N/A

33

N/A

N/A

= Food intake, carcass &
liver lipids;
Significant interaction DDT
× Exercise (glucose
tolerance)

156

138

Gestational rats (F0) were
treated and the third
generation (F3) were
observed
↑ Liver glycogen & TG;
= Liver phospholipid &
cholesterol

139

157

141

= Food intake;
↑ Liver weight w/ food
restriction (20);
↑ Liver hypertrophy w/ food
deprivation (200)

137

ɣ-HCH
(lindane)

↑ Food intake & food
efficiency (20 & 40);
↑ Liver weight;
40 caused death

Oral

Daily for
189 d;
daily for 15
wk

2.5

s.c.

Daily for 8
wk

M

N/A

↑

N/A

N/A

N/A

600

Oral

Daily for 8
wk

F/M

N/A

N/A

N/A

↓

=

140
(1/10
LD50)

Oral

Single,
tested after
2-8h

M

N/A

↑ at 2h
and return
to normal

N/A

N/A

↓ in
adrenal (2
& 6 h)

1

s.c.

Daily for 4
d
(PND1-4),
test in
adulthood

F/M

=

=

↑ in postprandial
♂, = in
fasting ♂;
↓ in ♀ (p
< 0.08)

↑ in ♂

↑ in ♂

= FFAs

147

5

s.c.

Daily for 4
m

F

↑ (starting
at 2 m)

N/A

N/A

N/A

N/A

↑ Perinephric fat weight;
= Weights of heart, liver &
gastrocnemius muscle

143

Oral

Daily for
35 d,
GND7PND21 to
dams

F&
pups

↑ in ♂
pups
starting at
PND 51
(2.5);
= in ♀
pups

N/A

↑ Body volume in ♂ pups at
PND 100;
↓ Weight/volume ratio in ♂
pups at PND 100;
↓ Leptin

144

5,10,20,
& 40

F

↑ (20 &
40)

N/A

N/A

N/A

N/A

138

Organophosphorus

Acephate

Chlorpyrifos

1, 2.5, &
4

N/A

N/A

34

N/A

↓ Liver glycogen;
↑ Pyruvic acid and lactic
acid in liver, heart, kidney,
brain & blood
↓ Total lipids;
Liver:
↑ Total lipids (↓ microsome,
= mitochondria, ↑ cytosol);
↑ Phospholipids & total
cholesterol (↓ microsome, ↓
mitochondria, & ↑ cytosol);
↑ FFA & TG;
↑ Corticosterone (2 & 6 h);
↑ Liver glycogen (6 h)
↓ Gluconeogenesis (G6P &
TAT) at 6 h;
= Weights of adrenals &
liver

158

159

160

40 (1/3
LD50)

40

i.p.

Single,
tested after
2h

i.p.

Single,
tested after
2h

F

F

↓ Brain glycogen; ↑ GP &
PGM; = G6P;
Atropine (cholinergic
blocker), tolazoline (αadrenergic blocker) and
propranolol (β-adrenergic
blocker) abolished or
reduced diazinon-induced
hyperglycemia & brain
glycogenolysis
↑ Lactic acid;
= Pyruvic acid;
Liver & brain:
↓ Glycogen;
↑ Glycogenolysis (↑ GP &
PGM, = G6P);
↑ Glycolysis (↑ HK & LDH,
brain only; = G6PD);
↑ Gluconeogenesis (↑ F1,6D
& PEPCK, liver only);
Adrenalectomy abolished
above changes

N/A

↑

N/A

N/A

N/A

N/A

↑;
abolished
by
adrenalectomy

N/A

N/A

N/A

↓ Phospholipids

162

Diazinon

161

126

128
(LD50) -1
d;
64 – 2d;
16 – 8d;
8 – 32 d

Oral

1 (single),
2, 8 or 32 d

M

N/A

N/A

N/A

↑ at 128;
= other
doses

10, 15 d
posttreatment:
↓ (64);
↓ (16);
= (4);
↓ HDL;
↑ LDL
(except ↓ at
16)

15, 30, &
60

Oral

Single,
tested after
2h

M

N/A

↑

N/A

N/A

N/A

Liver:
↑ GP & PEPCK (30 & 60)

163

15, 30, &
60 (1/20,
1/10, 1/5
LD50)

Oral

Single,
tested after
2h

M

N/A

↑

↓

N/A

N/A

↑ TNF-α; all effect
abolished by cAMP &
cGMP PDE inhibitor

164

75 (1/4
LD50)

Oral

Single,
tested after
28 d

M

N/A

↑

N/A

N/A

N/A

↑ Testosterone

165

35

6.5
(1/10
LD50)

Dichlorvos

Dimethoate

Isofenphos

i.p.

Single,
(tested
after 2 wk)

15, 30, &
60

i.p.

Single,
tested after
1 & 18 h

M

N/A

N/A

↓ (1h);
= (18h)

N/A

N/A

4 (1/20
LD50), 40
(1/2 LD50)

Oral

Single; 3,
7, 14 d

M

N/A

↑ (40)

N/A

N/A

N/A

6

s.c.

Daily for 8
wk

M

↓

↑

N/A

N/A

N/A

20
(1/4 LD50)

N/A

Single,
tested after
1 or 3 d

M

N/A

N/A

N/A

N/A

N/A

150

i.p.

15 & 30 d
(every
other days)

M

↑

= (15 d);
↑ (30 d)

↑

↑

= (15 d);
↑ (30 d)

20 & 40
(1/20 &
1/10
LD50)

Oral

20

Oral

2000

s.c.

500

i.p.

Malathion

Daily for
30 d

Single,
tested after
3-72h
Single,
tested after
0-6 h
Single,
tested after
0-48 h

Mg

=

=

=

↓

↓ (Wistar);
= HDL

M

↓ (40)

↑

N/A

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

F

N/A

↑

N/A

N/A

N/A

F

N/A

↑ (first 6
h)

N/A

N/A

N/A

36

↓ Glucose tolerance in GK;
= Glut4 in fat
↑ Langerhans islet GDH (1h,
30 & 60; 18h);
↑ Glutamate (1h; = 18 h)
↑ C-peptide;
↓ GDH gene expression
(18h, 60)
↓ Glucose tolerance;
Liver:
↑ GP & GS (40); ↓ uridine
diphosphate glucose
pyrophosphrylase
Brain:
↑ GP;
↓ Glycogen, HK, PFK, LDH
& glucose uptake
Liver:
↓ Glycogen & GK activity;
↑ GK mRNA level;
Pancreas:
= GK activity & mRNA;
= Insulin mRNA

166

167

168

146

169

170

↑ Lipase & amylase;
↓ Pancreas lipase &
amylase;
↓ Glucose tolerance;
↑ Pancreas weight;
= Weights of liver, kidney &
adrenals
↑ Muscle lipid;
↓ Sarcoplasmic esterase;
↓ Muscle lipase (13-18h)

145

171

172

↑ Liver, kidney, heart, &
spleen glycogen (all 6-12 h,
except liver 6-24 h);

131

= Brain glycogen

46 (1/25
LD50)

i.p.

15 d

M

N/A

=

N/A

N/A

N/A

650

i.p.

Single,
tested after
8h

M

N/A

↑

N/A

N/A

N/A

i.p.

Single,
tested after
2h

F

N/A

↑

N/A

N/A

N/A

125, 250,
& 500

i.p.

Single,
tested after
0.5,1, & 2
h

F

N/A

N/A

N/A

N/A

N/A

5,10, &
20

Oral
(Diet)

4 wk

M

N/A

↑

N/A

N/A

N/A

5,10, &
20

Oral
(Diet)

4 wk

M

N/A

↑ (10 &
20)

↑ (10 &
20)

N/A

N/A

100

Oral

Daily for
32 d

M

=

=

N/A

N/A

N/A

100

Oral

Daily for
32 d

M

N/A

=

N/A

N/A

N/A

500

37

↑ Liver glycogen,
Adrenaline (8 d),
noradrenaline (8 d) &
dopamine (4 d).

173

174

↑ Lactate; = pyruvate;
Brain:
↓ Glycogen;
↑ GP, PGM & HK;
= G6P & G6PD
Brain (500 except
glycogen):
↓ Glycogen (starting at 0.5
h);
↑ GP, PGM, HK & lactate;
=G6P, G6PD, LDH &
pyruvate;
Adrenalectomy abolish
these above changes;
↓ Succinic dehydrogenase;
Adrenal:
↓ Ascorbic acid;
↓ Cholesterol
↑ Liver PEPCK & GP
Muscle:
↑ PFK & GP (20);
= HK
↓ Food intake;
Liver:
↑ Weight, HK, & glycogen
；
↓ GP
↓ Liver lipids; ↑ glycogen;
↓ Muscle glycogen

175

125

176

177

129

130

Parathion

20

Oral

Daily for
28 d

M

N/A

↑

N/A

N/A

N/A

5,10, &
20

Oral
(Diet)

28 d

M

N/A

↑ (10 &
20)

↑ (10 &
20)

N/A

N/A

100
(1/21
LD50)

Oral

Single,
tested after
24 h

M

N/A

N/A

N/A

N/A

N/A

100 (1/21
LD50)

Oral

Daily for
32 d

M

N/A

N/A

N/A

↑

=;
= HDL &
LDL

F&M

♂: ↑
(0.1);
♀: ↓ (0.1
& 0.2);
↓ in ♀ w/
HFD
(0.2);

↑ (0.2) in
only
normal
diet

=

↓ only ♀
in the
fasted
state

↑ in ♂ w/
HFD;
↓ in ♀

N/A

N/A

= after 12h;
↑ after 24h

0.1 & 0.2

s.c.

Daily for 4
d (PND14)

Liver:
↑ PEPCK;
↑ Mitochondrial GP;
Administration of Satureja
khuzestanica essential oil
(225 mg/kg/day) abolished
the malathion induced effect
↓ Pancreas insulin secretion
(glucose stimulated);
= (KCl stimulated)
↑ Liver glycogen & HK;
↓ Liver GP;
Caffeic acid (100 mg/kg)
abolished these effects;
↓ Hypothalamic CRH
mRNA;
↑ iNOS; = nNOS
↓ Food intake in ♂ (0.2);
↑ Food intake in ♀ (0.1);
↓ HbA1c;
↓ FFA in ♀ w/ normal diet;
↓ β-hydroxybutyrate only in
fasted ♂

178

128

127

179

180

Carbamates

0.48,
0.96, 2.4,
& 4.8

s.c.

Single,
tested after
12 & 24h

M

N/A

↓ after
12h (0.48
& 0.96)
; ↑ after
12h (4.8);
↑ after
24h

Cismethrin

4

i.v.

Single

M

N/A

↑

N/A

N/A

N/A

↑ Noradrenaline, adrenaline,
& lactate

182

Cypermethrin

420
(1/10
LD50)

Oral
(Diet)

6m

M

N/A

=;
↑ in liver;

N/A

N/A

↓;
= in liver

N/A

183

Carbendazim

181

Pyrethroids

38

Decamethrin

Deltamethrin

0.06,
0.12, 0.3,
& 0.6

40

N/A

↑ after
12h (0.3
& 0.6); ↑
after 24h
(0.06)

N/A

N/A

↑ after 12h
(0.06 &
0.12); ↑
after 24 h
(0.3 & 0.6)

N/A

↑

N/A

N/A

N/A

↑ Lactate

184

N/A

↑

↑;
↑ LDL &
VLDL;
↓ HDL

↑ Total lipid;
Vitamin E attenuate adverse
effect of deltamethrin

185

↑

N/A

N/A

N/A

↑ Noradrenaline, adrenaline,
& lactate

182

↑ (20)

N/A

=

=

↓ Food intake (20);
↑ Weight of liver, kidney, &
adrenal (20)

150

s.c.

Single,
tested after
12 & 24h

M

i.p.

Single

F

1.28
(1/100
LD50)

Oral

Daily for
30 d

M

N/A

↑

1.5 & 2.6

i.v.

Single

M

N/A

0, 5, 10,
& 20

Oral

Daily for
90 d

F

↓ (20)

181

Neonicotinoids

Daily from
GND 6Imidacloprid
PND 21 to
10, 30, &
dams;
F&
186
Oral
=
N/A
N/A
N/A
N/A
90
Daily from pups
PND21PND 42 to
pups
a mg/kg BW/day unless otherwise specified (e.g. in diet), * doses are ppm in diet; NOAEL, no observed adverse effect level;
b s.c., subcutaneous injection; i.p., intraperitoneal injection; i.v., intravenous injection
c d, day(s); h, hour(s); m, month(s); wk, week(s); w/o, without; PND, postnatal days; GND, gestational day;
d F, female; M, male;
e Results are for all doses tested in each study, unless doses are indicated as numbers in parenthesis; all markers are from fasting blood samples unless otherwise specified; ↑, increase;
↓, decrease; = no change; w/, with; ♂, male; ♀, female; N/A, not available;
f apoE3 & C57BL/6N strain were used; gGK (Goto-Kakizaki) rats are a spontaneous animal model of non-insulin-dependent diabetes without obesity;
Acronyms used: ACC-1, Acetyl-CoA carboxylase 1; pACC, phosphorylated ACC; pAkt, phosphorylated Akt; AMPKα, AMP-activated protein kinase alpha; pAMPKα,
phosphorylated AMPKα; BW, body weight; cAMP, cyclic adenosine monophosphate; CaMKKβ, calcium/calmodulin-dependent protein kinase kinase β; CD36, cluster of
differentiation 36; CEBPα, CCAAT/enhancer-binding protein α; cGMP, cyclic guanosine monophosphate; CPT1, carnitine palmitoyltransferase I; CRH, corticotropin-releasing
hormone; FA, fatty acid; FFAs, free fatty acids; FABP4, fatty acid binding protein 4; F1,6D, fructose 1,6-bisphosphatase; GDH, glutamate dehydrogenase; GK, glucokinase; GK rat,
Goto-Kakizaki rat; Glut2, glucose transporter 2; Glut4, glucose transporter 4; G6P, glucose-6-phosphatase; G6PD, glucose-6-phosphatase dehydrogenase; GP, glycogen
phosphorylase; GS, glycogen synthase; GTT, glucose tolerance test; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; HFD, high-fat diet; HK, hexokinase; HOMA-IR,
homeostatic model assessment-insulin resistance; iNOS, inducible nitric oxide synthase; IL-6, interleukin 6; LDH, lactate dehydrogenase; LFD, low-fat diet; LPL, lipoprotein lipase;
nNOS, neuronal nitric oxide synthase; PDE, phosphodiesterase inhibitor; PDK4, pyruvate dehydrogenase lipoamide kinase isozyme 4; PEPCK, phosphoenolpyruvate carboxykinase;
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PFK, phosphofructokinase; PGC-1α, peroxisome proliferator-activated receptor gamma co-activator 1; PGM, phosphoglucomutas; PK, pyruvate kinase; PPARɣ, peroxisome
proliferator-activated receptor gamma; SCD-1, stearoyl-CoA desaturase-1; Sirt 1, NAD-dependent deacetylase sirtuin-1; SREBP1, sterol regulatory element-binding protein 1; TAT,
tyrosine aminotransferase; TG, triglycerides; TNFα, tumor necrosis factor-α; VLDL, very low-density lipoprotein.
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2.4 Mechanism of insecticides-induced change in glucose and lipid metabolism
Recent studies indicate that insecticides are reported to influence various organs
and tissues, such as endocrine organs, liver, pancreas, muscle, and adipose tissue, which
may lead to altered glucose and lipid metabolisms 30, 187-195. A number of mechanisms
were suggested to be influenced by insecticides; including oxidative stress and
endoplasmic reticulum stress.

2.4.1 Liver
The liver, as one of the principal organs in regulation of glucose homeostasis,
contributes to blood glucose level by maintaining a balance between storage of glucose
via glycolysis and glycogenesis and release of glucose via glycogenolysis and
gluconeogenesis 129, 176, 196-198. It was suggested that since insecticides are designed to
target the nervous system, exposure to insecticides may attribute to increased liver
glucose production to meet the increased energy demand caused by overstimulation of
the nervous system 163. In fact, studies have demonstrated that exposure to certain
insecticides can increase the activities of key enzymes involved in hepatic
gluconeogenesis and glycogenolysis 126, 158, 163, 169, 176, 178, 199, 200. Organophosphorus
insecticides were shown to increase hepatic phosphoenolpyruvate carboxykinase (a key
enzyme for gluconeogenesis) and glycogen phosphorylase (a key enzyme for
glycogenolysis) in both in vitro and in vivo 163, 176, 178, 200. Others, however, reported that
insecticides increased hepatic glycogen levels by organochlorine (dieldrin) and
organophosphorus (malathion) 131, 157. The inconsistent results obtained from different
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studies may be explained by initially increased blood glucose level caused by
gluconeogenesis and glycogenolysis (the maximum increase was noted at 2 h after
administration), followed by glycogenesis, and a return to normal blood glucose level 6–
24 h after malathion treatment 129, 130.

2.4.2 Muscle
Muscle is tightly linked with the nervous system by neuromuscular junctions, thus
susceptible to insecticide-induced neurotoxic effects. Previous reports have exhibited that
exposure to malathion, an organophosphorus insecticide, decreased glycogen content in
muscles 130, 177. In particular, Pournourmohammadi et al. reported that this was due to
increased activities of glycogen phosphorylase and phosphofructokinase (PFK), which
are the key enzymes regulating glycogenolysis and glycolysis, respectively 177. In
addition, permethrin (a pyrethroid insecticide) and imidacloprid (a neonicotinoid
insecticide) were previously shown to induce insulin resistance in C2C12 muscle cells via
Akt signaling 24, 201.

2.4.3 Pancreas
Excessive stimulation of the cholinergic receptors by insecticides can result in
disturbance of insulin and glucagon secretions, potentially due to pancreas tissue damage.
Thus, insecticides that influence either acetylcholine level or its receptors by inhibiting
acetylcholine esterase (organophosphorus and carbamates) or by acting as agonists to
nicotinic acetylcholine receptors (neonicotinoids) can all potentially stimulate insulin
release from the pancreas. Studies have found that exposure to malathion, an
organophosphorus insecticide, resulted in elevated blood insulin levels in rats 128, 177.
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Another study, however, found that exposure to malathion resulted in decreased glucosestimulated insulin secretion accompanied with patchy degenerative changes in the islets
of Langerhans 128. Similarly, other human and animal studies also found that
organophosphorus and carbamate insecticides can cause acute pancreatitis, which
potentially influence insulin secretion 119, 202-212.

2.4.4 Adipose tissue
It is suggested that many lipophilic insecticides, such as DDE, malathion, or
permethrin, can be easily trapped and stored in adipose tissues 128, 213, 214. In addition, in
vitro studies using 3T3-L1 adipocytes demonstrated that DDT 215, 216, DDE 216, 217,
imidacloprid 23, and permethrin 201, potentiated adipogenesis. Another study, however,
found that treatment of DDE to 3T3-L1 cells did not alter adipogenesis or lipolysis, but
increased basal free fatty acid uptake and the release of leptin, resistin, and adiponectin,
which may be potentially linked to increased risk of obesity and type 2 diabetes 218. The
same study also reported that oxychlordane and dieldrin (both organochlorines) increased
basal free fatty acid uptake, but not insulin-stimulated glucose uptake in 3T3-L1
adipocytes 218.

2.4.5 Endocrine organs and brain
Currently more than 101 pesticides have been listed as proven or possible
endocrine disruptors by the Pesticide Action Network UK 191. Some of the insecticides
disrupt the endocrine system by mimicking the action of estrogen. For example, certain
organochlorines and carbamates were reported to inhibit androgen receptors; some
organophosphorus insecticides were reported to increase the expression of estrogen
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responsive genes; and certain pyrethroids potentiate the action of estrogen 195. The
endocrine disrupting activities of pesticides may potentiate the risk of obesity and type 2
diabetes and other related diseases 219, 220.
Along with altered glucose homeostasis, organophosphorus compounds have been
demonstrated to elevate catecholamine levels 125, 173, 177, 221-225, which are abolished by
adrenalectomy 125, 126. This suggests a role of adrenal glands in organophosphorusinduced disturbance of glucose homeostasis.
Pyrethroids were reported to inhibit progesterone action, organophosphorus
insecticides were shown to inhibit thyroid hormone receptor 195, and exposure to an
organophosphorus, diazinon, was previously reported to increase the serum testosterone
levels 165. Organochlorine and carbamate insecticides showed anti-androgenic effects by
inhibition of binding natural ligand to androgen binding receptors 191. All these hormones
are known to influence insulin sensitivity and glucose homeostasis 226-228. It was
suggested that insecticides were able to act as an agonist or an antagonist towards aryl
hydrocarbon receptors and certain nuclear receptors, such as retinoic acid receptors,
pregame X receptors, and peroxisome proliferator-activated receptors 229, 230.
Studies have reported decreased brain glycogen content with increased activity of
glycogen phosphorylase by organophosphorus insecticide, malathion 126, 175 and
dichlorvos 146. It was suggested that malathion can interfere with oxygen uptake and
promoted glycogenolysis and glycolysis in favor of anaerobic conditions to counteract
the neurotoxic effects in rats 175. Malathion was also shown to increase lactic acid
concentration without altering pyruvate content in the brain 125. Others reported that an
organochlorine insecticide (dieldrin) can cause apoptosis and neural degeneration by
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increasing acetylation of core histone H3 and H4 in neuronal cells 231. Limited studies
reported that exposure to insecticides could affect feeding behavior by acting on the
neural circuits 191. When low doses of imidacloprid or permethrin (at or lower than
NOAEL) were administered in mice, no significant effects of either insecticide on food
intake were observed 132-134.

2.4.6 Cellular Responses
2.4.6.1 Oxidative stress
Oxidative stress was often suggested to be associated with insecticide-induced
toxicity in vitro and in vivo 163, 191, 194, 232-239. It is also known that oxidative stress is
linked with obesity and type 2 diabetes 240. Thus, many mechanistic studies have
suggested that insecticides disrupt glucose and lipid metabolisms via oxidative stressmediated mechanisms, such as lipid peroxidation, mitochondrial dysfunction, inhibition
of paraoxonase and glucose-6-phosphate dehydrogenase (G6PD), and nitrosative stress 30,
127, 187, 191, 194, 238, 241-244

.

Glucose plays a critical role as an antioxidant against free radicals via the pentose
phosphate pathway, in which nicotinamide adenine dinucleotide phosphate (NADP) is
reduced to NADPH, which is subsequently used for the reduction of oxidized glutathione
(GSH) from disulfides of GSH (GSSG) and cellular proteins 163. The increased demand
of glucose to counteract the increased reactive oxygen species induced by insecticides has
been suggested to cause hyperglycemia, leading to stimulated hepatic glycogenolysis and
gluconeogenesis pathways 163. In fact, some studies found that antioxidants could
attenuate insecticide-induced hyperglycemia 178, 185.
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Abnormal mitochondrial respiratory chain functions can cause disturbance in
intracellular energy homeostasis and has been involved in many diseases, including
diabetes 245-248. Exposure to insecticides can cause muscle fasciculation, which greatly
increase the oxygen flow into corresponding tissues and organs 178, 187, 237, 238. And this
increased oxygen flow caused by insecticides may lead to elevated oxidative
phosphorylation in mitochondria, which subsequently increase the production of reactive
oxygen species as byproducts. In addition, some insecticides (rotenone or pyridaben) are
known to disrupt mitochondrial respiratory chain reaction, mainly by inhibiting Complex
I, II, III and V electron transport chain 249.
Studies have demonstrated that pancreatic beta cell failure induced by insecticide
exposure could be the result of underlying mitochondrial dysfunction in the pancreas 191,
250, 251

. It is reported that the pancreas is more susceptible to reactive oxygen species than

other tissues because of its relative low expression of defensive enzymes against reactive
oxygen species 252-254.
Besides their inhibiting effect on acetylcholine esterase activity,
organophosphorus compounds were reported to inhibit other esterases, such as the
paraoxonase, a key enzyme involved in hydrolysis of oxons (active organophosphorus
metabolites), which may potentially increase oxidative stress 255.
cAMP and cGMP signaling may also play an important role in insecticideinduced oxidative stress. Previous studies have found that increased cyclic nucleotides
using phosphodiesterase inhibitors could protect against organophosphorus-induced lipid
peroxidation in rat submandibular saliva 221 and liver cells 222. Similarly, another report
supported that increased intracellular levels of cAMP and cGMP by intraperitoneal
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administration of phosphodiesterase inhibitors could exert protective effects against
organophosphorus-induced hyperglycemia and oxidative/nitrosative stress in Langerhans
islets cells in rats 164.

2.4.6.2 Endoplasmic reticulum stress
Recent studies have found endoplasmic reticulum (ER) stress play key roles in
development of several chronic diseases, including obesity and type 2 diabetes 256-260.
There are a few studies reporting a correlation between several types of insecticides and
ER stress. An organochlorine (endosulfan), carbamates (formetanate, methomyl,
pyrimicarb), and a pyrethroid (bifenthrin) were reported to increase 78 kDa glucoseregulated protein GRP78, also known as binding immunoglobulin protein (BiP), which is
one of the ER stress markers in human pulmonary A549 cells 261, 262. Another pyrethroids
insecticide, deltamethrin, was reported to induce ER stress in SK-N-AS neuroblastoma
cells via elevation of intracellular calcium level and activation of eukaryotic translation
initiation factor 2α (eIF2α) 42. Currently, there is no study directly determining the role of
ER stress caused by insecticides and development of obesity and type 2 diabetes.

2.4.6.3 Inflammatory responses
Inflammation plays essential role in protecting cells from harmful stimuli (e.g.
pathogens, damaged cells, or irritants) by involving immune cells and inflammatory
cytokines [e.g., tumor necrosis factor alpha (TNFα)] 263. Recent evidence demonstrated
that inflammation responses are also linked with the development of obesity and type 2
diabetes 263, 264. Studies showed that exposure to insecticides disturbed glucose and lipid
metabolism via increasing inflammatory responses in vitro and in vivo 134. Imidacloprid,
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a neonicotinoid insecticide, was reported to increase TNFα gene expression in fat tissue
of male mice 134. Acute oral exposure to diazinon, an organophosphorus insecticide, was
reported to increase TNFα level in Langerhans islets of male rats 164. Permethrin, a
pyrethroid insecticide, increased the gene expression of TNFα in adipose tissue of male
mice and 3T3-L1 adipocytes (Figure 6.5, Figure 4.5), which may be achieved by
upregulation of Jun N terminal kinase (JNK) and CCAAT/enhancer binding protein
homologous protein (CHOP) in the ER stress pathway (Section 6.4).

2.5 Conclusion and project rationale
The literature review has discussed that exposure to insecticides can disturb
glucose and lipid homeostasis and potentially increase the risk of developing obesity and
type 2 diabetes. Previous studies have largely focused on organochlorine and
organophosphorus insecticides, with less studies on carbamates, pyrethroids and
neonicotinoids. Furthermore, knowledge of how and when these metabolic perturbations
may ultimately contribute to the development of obesity and related pathologies is also
limited. Considering the currently wide use of pyrethroids and the declining use of
organochlorines and organophosphorus, it is important to investigate the effects and
mechanistic details of pyrethroids on alteration of glucose and lipid metabolism in vitro
and in vivo. Permethrin is the single most widely used pyrethroid insecticide, accounting
for ~60% of all pyrethroids 265. It was previously shown that exposure to permethrin can
potentiate adipogenesis in 3T3-L1 adipocytes and insulin resistance in C2C12 cells in
vitro 201; however, the effects of permethrin on glucose and lipid metabolisms in vivo and
the mechanisms of how permethrin induce adipogenesis and insulin resistance in vitro
have not been fully explored. The dissertation herein will evaluate the role of permethrin
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on glucose and lipid metabolism in vivo and the molecular mechanisms of permethrinpotentiated adipogenesis in 3T3-L1 adipocytes.
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CHAPTER 3
OBJECTIVES OF THE PROJECT
The long-term goal is to develop prevention and/or treatment strategies for
obesity and type 2 diabetes. The objective of this project is to determine the potential
contribution of permethrin (a pyrethroid insecticide) on development of obesity and
diabetes. The central hypothesis is exposure to permethrin will alter lipid metabolism and
glucose homeostasis along with dietary fat, resulting in potentiated weight gain and
impaired insulin responses. The rationale of this proposed research is: by understanding
biochemical mechanisms by which exposure to environmental contaminants (permethrin
in this case) may result in development of obesity and type 2 diabetes, we will be able to
direct more efficient prevention and/or treatment strategies for these and related
pathologies now and in the future.
The project aims are as follows:
Specific Aim 1: Determine the effects of permethrin and dietary fat interaction on
development of obesity and type 2 diabetes in vivo. The hypothesis to be tested is
permethrin will potentiate high-fat diet induced weight gain and development of insulin
resistance in a dose-dependent manner.
Specific Aim 2: Determine the mechanism of permethrin on impaired lipid
metabolism in 3T3-L1 adipocytes. The hypothesis to be tested is permethrin promotes
adipogenesis by a calcium- and ER stress-dependent mechanisms.
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CHAPTER 4
EXPOSURE TO PERMETHRIN PROMOTES HIGH-FAT-INDUCED WEIGHT
GAIN AND INSULIN RESISTANCE IN MALE C57BL/6J MICE
4.1 Introduction
Permethrin [(±)-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2dimethylcyclopropanecarboxylate] is one of the synthetic pyrethroid insecticides
structurally based on the natural pyrethrins. First synthesized in 1973 and marketed in
1977, permethrin is a photo-stable ester composed of the dichloro analogue of
chrysanthemic acid and the 3-phenoxybenzyl alcohol 266. Four different stereoisomers
can be found in the technical grade of permethrin products, and among these isomers, one
with the [1R, cis] configuration is known to be the most potent form against insects
(WHO 1990). In addition to the structural advancement for the enhanced environmental
stability, permethrin exhibits excellent potency against a wide spectrum of insect pests,
while retaining a large margin of mammalian safety 14-16.
The action of permethrin on its molecular targets has been extensively studied and
well-reviewed previously 18, 267, 268. Briefly, permethrin elicits a rapid functional
disruption in the neuromuscular system by membrane depolarization. One of the
important major target sites is located on the voltage sensitive sodium channel (VSSC)
alpha-subunit, a pore forming transmembrane protein that consists of four homologous
domains (I-IV) 17, 18. Permethrin is known to slow the inactivation of VSSCs and
produces the prolonged tail currents upon repolarization of the cell membrane under
voltage-clamp electrophysiological recording conditions 267, 269, 270.
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Permethrin in mammals can be quickly biotransformed by ester cleavage and
oxidation reactions and almost completely eliminated via urinary and fecal excretions
within 12 days 16. Environmental fate of permethrin varies depending on the
environmental conditions. A half-life of permethrin in soil under aerobic conditions has
been estimated to be 28 days or less under laboratory study conditions 16. In fact,
permethrin can be degraded and disappeared from the environment rapidly (several hours
to 58 days) by photolysis, microbial and plant bio-transformations, while very little
movement in the soil 16. Based on these characteristics, permethrin became the first
pyrethroid to be used under a wide range of environmental conditions, approximately
17% of the global insecticide market was occupied by pyrethroid products by 2013 15, 18,
39

. In the US alone, ~2.2 million lbs of permethrin have been sprayed annually to

agricultural plots, residential areas and approximately 63% is applied to the residential
area for public health 19. Permethrin has been formulated in pet products and veterinary
medications to control ectoparsitic arthropod pests, such as ticks and fleas. An over-thecounter 1% permethrin formulation for human head louse control has been available to
treat infested school aged children 20, 21. Additionally, many biting arthropods show
avoidance behaviors to permethrin, hence many permethrin-treated materials (e.g.,
permethrin impregnated clothing including military uniforms, pet collars, and mosquito
nets) have been developed and used to repel blood feeding arthropods 271. The
commercial availability of those pyrethroids suggests that human exposure to permethrin
is unavoidable.
Previously, permethrin was reported to promote adipogenesis and induce insulin
resistance in cell culture models similar to other types of membrane-depolarizing
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insecticides 23-26; however, there is a lack of in vivo study determining the effect of
permethrin on glucose and lipid metabolisms. Thus, the purpose of this study is to
investigate the effect of permethrin exposure on development of dietary-fat-induced
obesity and type 2 diabetes using a mouse model.

4.2 Materials and methods
4.2.1 Materials
Permethrin (98%, mixture of cis and trans isomers) was from Sigma Aldrich Co.
(St. Louis, MO). Insulin (human recombinant) was obtained from Novo Nordisk Inc.
(Princeton, NJ). D-glucose solution (50%) was acquired from Hospira Inc. (Lake Forest,
IL). Triglyceride (TG), cholesterol, glucose, and Pierce BCA protein assay kits were
purchased from Thermo Scientific (Rockford, IL). Insulin ELISA kit was from ALPCO
(Salem, NH). Leptin ELISA kit was purchased from R&D systems (Minneapolis, MN).
Non-esterified fatty acid (NEFA) assay kit was from Wako Diagnostics (Richmond, VA).
Rabbit antibodies of phosphorylated adenosine monophosphate-activated protein kinase α
(pAMPKα), adenosine monophosphate-activated protein kinase α (AMPKα),
phosphorylated acetyl-CoA carboxylase (pACC), and acetyl-CoA carboxylase (ACC)
were purchased from Cell Signaling Technology (Danvers, MA). Mouse antibody of βactin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies were
also from Cell Signaling Technology (Danvers, MA). High capacity cDNA reverse
transcription kit, real time PCR primers and Taqman gene expression master mix were
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obtained from Applied Biosystem (Carlsbad, CA). Other chemicals were either from
Thermo Fisher Scientific (Waltham, MA) or Sigma-Aldrich (St. Louis, MO).

4.2.2 Animals and diet
All animal care and procedures were approved by the Institutional Animal Care
and Use Committee of the University of Massachusetts Amherst (Protocol # 2013-0014).
Male C57BL/6J mice at 3 week of age from the Jackson’s Laboratory (Bar Harbor, ME)
were housed in pairs with a 12-h light-dark cycle in a temperature and humidity
controlled room. Mice were adapted to new environment with low-fat semi-purified AIN93-based diet in powdered form (TD94048, Harlan Laboratories, Madison, WI) for 3
weeks. All mice were given a baseline insulin tolerance test (ITT) in the 2nd week of
adaptation and a baseline glucose tolerance test (GTT) in the 3rd week of the adaptation
period. Then, animals were randomly divided into two dietary groups: low-fat (4 w/w %
fat) and high-fat diet groups (20 w/w % fat, TD07518, Harlan Laboratories, Madison,
WI). The diet composition is shown in Table 4.1. Permethrin was first dissolved in
soybean oil and then mixed with other ingredients. Within each dietary fat group, control
(without permethrin) and three difference doses of permethrin-containing diet were given
to mice for 12 weeks. Body weight and food intake were measured weekly. Permethrin
doses used in the current study were chosen based on acceptable daily intake (ADI) of
permethrin of 50 μg/ kg body weight (BW)/day and the chronic no observed effect level
(NOEL) of permethrin of 5000 μg/kg body weight/day 272, 273. Permethrin concentration
in low-fat diet were 0.43, 4.3 & 43 microgram per gram of diet to deliver 50 µg/kg
BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day, respectively. For high-fat diet,
actual permethrin concentration is 0.62, 6.2 & 62 microgram per gram of diet to deliver
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50 µg/kg BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day, respectively. Estimated
permethrin intake in low-fat diet fed animals were 58 ± 1 µg/kg BW/day, 594 ± 1 µg/kg
BW/day and 6184 ± 151 µg/kg BW/day to deliver 50 µg/kg BW/day, 500 µg/kg BW/day
and 5000 µg/kg BW/day, respectively. Estimated permethrin intake in high-fat diet fed
animals were 72 ± 1 µg/kg BW/day, 610 ± 47 µg/kg BW/day and 6422 ± 133 µg/kg
BW/day to deliver 50 µg/kg BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day,
respectively. There were no significant differences on 3 permethrin doses delivered
between high- vs. low-fat diets.
After 12 weeks of permethrin treatment, mice were sacrificed by CO2
asphyxiation after 4 h of fasting. Blood was collected after cardiac puncture and serum
were separated by centrifugation at 3,000 g for 20 mins at 4 °C. Internal organs [heart,
liver, kidneys, pancreas, spleen and adipose tissue including epididymal, retroperitoneal,
mesenteric and subcutaneous fat from abdominal area] were weighed, snap-frozen by
liquid nitrogen and kept in -80C for further analysis. A part of epididymal white adipose
tissue was directly preserved in 10% neutralized formalin for histological analysis.
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Table 4.1. Composition of experimental diet
Ingredient

Low-fat Diet
140

High-fat Diet
169.1

1.8

2.2

Corn starch

465.7

288.5

Maltodextrin

155

132

Sucrose

100

100

Soybean oil

40

200

Cellulose

50

50

Mineral Mix, AIN-93M-MX (TD 94049)

35

42.8

Vitamin Mix, AIN-93-VX (TD 94047)

10

12.4

Choline Bitartrate

2.5

3

tert-Butylhydroquinone (TBHQ)

0.008

0.04

Total

1000

1000

Casein
L-cystine

4.2.3 Determination of glucose homeostasis
Insulin tolerance test was carried out three times (2nd week of adaptation period,
week 5 and week 9) according to the method described previously 274. Mice were fasted
for 4 hours before a bolus of insulin (0.75 U/kg) was injected intraperitoneally. Then, tail
vein blood sample were obtained at 0, 15, 30, 60 and 120 minutes after insulin injection
and tested for glucose level using a hand-held glucometer (Advocate, Pharma Supply Inc,
Wellington, FL). The areas under the curve (AUC) were calculated using SigmaPlot 11.0
(Systat Software, Inc., San Jose, CA).
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Intraperitoneal glucose tolerance test (IPGTT) were conducted at the 3rd week of
adaptation, week 6 and week 11 according to a method described by Andrikopoulos and
colleagues but with slight modification 275. After 6 hours of fasting, a bolus of glucose
solution (2 g/kg) was injected into the intraperitoneal cavity of each mouse. Blood
glucose level was then measured at 0, 15, 30, 60, 120 min using a glucometer as
described above. Blood samples at 0, 30, 60, 120 min were also obtained for insulin
determination by lateral tail incision using a method described previously 276.
Homeostatic model assessment-insulin resistance (HOMA-IR) was calculated using
HOMA2 calculator provided by University of Oxford 277.

4.2.4 Hematoxylin and eosin staining
Epididymal adipose tissues were fixed with 10% neutralized formalin solution
before embedding into paraffin. 5-m-thick sections were made for hematoxylin and
eosin staining of nuclei and cytoplasma, respectively. Adipocyte size measurement was
conducted by four individuals who were blinded to the treatment groups using ImageJ
software (U.S. National Institutes of Health).

4.2.5 Western blot analysis
Immunoblot analysis was done based on a previous method 278. Briefly,
radioimmunoprecipitation assay buffer (Thermo scientific, Rockford, IL) containing
protease & phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL) was used to
homogenize and extract proteins from epididymal adipose tissue and liver samples. The
sample lysates were then centrifuged and supernatant was used for protein quantification,
and subject to electrophoresis using sodium dodecyl sulfate-polyacrylamide gel (SDS-
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PAGE). After transferring to polyvinylidene fluoride membrane (Millipore, Bedford,
MA), samples were incubated with primary and horseradish-conjugated secondary
antibodies. Detection was performed using Image Station 4000MM instrument
(Carestream Health, New Heaven, CT) by using Clarity ECL western blot substrate (BioRad, Hercules, CA). Results were analyzed by ImageJ software (U.S. National Institutes
of Health). Protein levels were normalized with β-actin protein concentration.

4.2.6 mRNA expression
The liver, gastrocnemius skeletal muscle and epididymal adipose tissue were
homogenized using TRIzol reagent and total RNA was extracted according to
manufacturer’s protocol. Total RNA was subsequently reverse transcribed to cDNA
using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystem, Carlsbad,
CA). TaqMan Gene Expression Assays for [Glucose transporter 4 (GLUT4,
Mm00436615_m1), Sterol regulatory element-binding protein 1 (SREBP1,
Mm00550338_m1), diacylglycerol O-acyltransferase 1 (DGAT1, Mm00515643_m1),
diacylglycerol O-acyltransferase 2 (DGAT2, Mm00499536_m1), cluster of
differentiation 36 (CD36, Mm00432403_m1), phosphoenolpyruvate carboxykinase 2
(PEPCK, Mm00551411_m1), pyruvate dehydrogenase kinase 4 (PDK4,
Mm01166879_m1) were performed on StepOne Plus real time PCR instrument (Applied
Biosystems, Carlsbad, CA). The oligonucleotide primers for TNFα (NM_013693.2) were
purchased from Eurofins MWG Operon (Huntsville, AL). Threshold values were
analyzed by comparative CT (∆∆CT) method 279. Relative quantities of gene expression
with real-time quantitative PCR (RT-qPCR) were calculated relative to 18S ribosomal
RNA.
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4.2.7 Statistical analysis
Data were analyzed by PROC MIXED using the SAS software (Version 9.3, SAS
Institute Inc., Cary, NC, USA). Body weight (Figure 1A) data were analyzed by two-way
repeated measure Analysis of Variance (ANOVA) and the slice option in the Least
Square (LS) means statement. All the other results were analyzed by two-way ANOVA
with LS means statement. The Tukey-Kramer’s method was used for the multiple
comparisons among the experimental groups. Letters (a, b, c, etc.) were used to present
differences between each experimental group if there were significant interactions
between diet and permethrin. p-values less than 0.05 were reported as statistically
significant.
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4.3 Results
4.3.1 Permethrin promoted weight gain without influencing energy intake in highfat fed mice
There was a significant effect of dietary fat (p < 0.0001), permethrin (p = 0.0478)
and time (p < 0.0001) on body weight (Figure 4.1A). There was a significant three-way
interaction (diet × permethrin × time) (p = 0.0057). Similarly, there was a significant
effect of diet and permethrin treatment with significant interaction on body weight gain
(Fig. 4.1B). These results suggest that permethrin promoted weight gain along with highfat diet. There was significant effect of diet on energy intake (low-fat diet 4677.84 ±
56.26 kilojoules (KJ); high-fat diet 5007.39 ± 110.77 KJ), without permethrin effects or
interaction (Fig. 4.1C).
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Figure 4.1. Effects of permethrin treatment on body weight (A), weight gain (B) and
energy intake (C) in male C57BL/6J mice. Mice were treated with either control or
permethrin-containing diet [50, 500, 5000 µg/kg body weight (BW)/day] for 12 weeks in
either low-fat or high-fat diet. (A) Blank symbols, low-fat fed mice; Filled symbols, highfat fed mice. Circles, control; Up-triangles, 50 µg/kg BW/day; Down-triangles 500 µg/kg
BW/day; Squares, 5000 µg/kg BW/day. Values represent means ± S.E. (n= 5-8). Means
with different letters are significantly different (p < 0.05).
4.3.2 Effect of permethrin on organ weights and adipocyte size
Organ weights (liver, pancreas, heart, kidneys, and spleen) as well as adipose
tissue weights (epididymal, subcutaneous, mesenteric, retroperitoneal, and total adipose
tissue) are shown in Table 4.2. There were significant effects of diet on heart (p =
0.0001), kidney (p = 0.0007) and spleen (p = 0.0001) weights, but not liver and pancreas
weights. Permethrin treatment had no significant effect on any of the organ weights
(Table 4.2.). Significant diet and permethrin interactions were observed for heart and
kidney weights.
There was a significant effect of diet on adipose tissue weights (Table 4.2., p <
0.0001 for all) as well as permethrin with an exception of mesenteric adipose tissue mass
(p < 0.05 for all) with significant interactions (p < 0.05). Specifically, permethrin
treatment in high-fat diet significantly increased total adipose tissue mass compared to
high-fat control (p < 0.0001 with 500 µg/kg BW/day and p = 0.0002 with 5000 µg/kg
BW/day), while no effects of permethrin was observed in low-fat diet groups.
Consistently, adipocyte cell sizes were significantly increased by high-fat diet (p <
0.0001) and permethrin treatment (p = 0.046), while no diet and permethrin interaction
was observed (Fig. 4.2B). Permethrin treatment at 500 and 5000 µg/kg BW/day
significantly increased adipocyte size over control.
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Figure 4.2. Effects of permethrin treatment on epididymal adipocyte size in male
C57BL/6J mice. Mice were treated with either control or permethrin-containing diet (50,
500, 5000 µg/kg body weight/day) for 12 weeks in either low-fat or high-fat diet. Values
represent means ± S.E. (n= 3).
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Table 4.2. Effects of permethrin and dietary fat on organ weights (% of body weight) in male C57BL/6J mice
Low-fat

High-fat
p-value

Permethrin doses

Permethrin doses

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Dietary
fat

Perm

×

Liver

3.90±0.12

3.60±0.23

3.95±0.23

3.59±0.17

3.51±0.18

3.33±0.21

3.67±0.13

3.64±0.07

n.s.

n.s.

n.s.

Pancreas

0.43±0.04

0.50±0.05

0.46±0.01

0.44±0.02

0.54±0.05

0.45±0.04

0.36±0.03

0.38±0.03

n.s.

n.s.

n.s.

Heart

0.44±0.02ab

0.49±0.03a

0.48±0.02a

0.52±0.01a

0.47±0.03ab

0.43±0.02ab

0.35±0.04b

0.35±0.02b

0.0001

n.s.

0.0025

Kidneys

1.06±0.05abc

1.12±0.04a

1.07±0.04abc

1.11±0.01ab

1.12±0.07a

0.99±0.02abc

0.88±0.05bc

0.87±0.04c

0.0007

n.s.

0.0125

Spleen

0.30±0.02

0.28±0.04

0.30±0.03

0.30±0.04

0.26±0.03

0.21±0.01

0.17±0.02

0.18±0.02

0.0001

n.s.

n.s.

Epididymal

2.19±0.20c

2.19±0.17c

1.74±0.17c

1.79±0.14c

3.57±0.42b

4.57±0.27ab

5.65±0.17a

5.41±0.43a

<.0001

0.0209

0.0001

Subcutaneous

1.36±0.24d

1.47±0.15cd

1.05±0.08d

1.05±0.17d

2.65±0.45c

3.39±0.29b

4.63±0.50ab

4.95±0.21a

<.0001

0.0093

0.0002

Mesenteric

1.32±0.09c

1.52±0.13bc

1.22±0.06c

1.12±0.10c

2.02±0.23ab

2.17±0.14a

2.74±0.22a

2.52±0.19a

<.0001

n.s.

0.0149

Retroperitoneal

0.59±0.08c

0.63±0.09c

0.39±0.05c

0.42±0.07c

1.09±0.12b

1.56±0.11a

2.00±0.09a

1.77±0.09a

<.0001

0.0016

<.0001

Adipose tissue
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Total

5.45±0.57c

5.81±0.46c

4.40±0.28c

4.38±0.46c

9.34±1.13b

11.70±0.69ab

15.02±0.85a

14.65±0.62a

<.0001

Mice were treated with three doses of permethrin (50, 500, & 5000 µg/kg body weight/day). Values represent means ± SE (n=5-8).
Means with different superscripts within the same row are significantly different at P<0.05. Abbreviations: n.s., not significant; Perm, permethrin; ×, interaction
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0.0085

<.0001

4.3.3 Effect of permethrin on glucose homeostasis
To determine the role of permethrin in diet-induced insulin resistance, ITT, GTT,
the measurement of insulin during GTT, and HOMA-IR calculations were made. There
were no significant differences on insulin responsiveness measured by ITT, GTT, insulin
levels, or HOMA-IR during adaptation period (Fig. 4.3A, 4.3D, 4.3G, and Fig. 4.4A,
respectively). In weeks 5 & 9, the high-fat diet group showed significantly increased
insulin resistance versus the low-fat fed group (p = 0.0006 and <0.0001, respectively,
Fig. 4.3B & 4.3C). Permethrin treatment only showed significant effect on insulin
responsiveness in week 9 (p = 0.0256) with significant interaction (p < 0.0001) (Fig. 4.3B
& 4.3C). In the high-fat dietary groups, animals with the middle and highest dose of
permethrin (500 µg/kg BW/day and 5000 µg/kg BW/day, respectively) showed
significantly increased insulin resistance when compared to high-fat control and the low
dose of permethrin at week 9 (Fig. 4.3C). However, no significant effect of permethrin
treatment was found between low-fat groups. At weeks 6 & 11, there were significant
effects of dietary fat (p < 0.0001for GTT (Figure 4.3E & 4.3F), with a significant
permethrin (p = 0.0198) and interaction effect (p = 0.0061) in week 11 only. In the highfat dietary groups, animals with permethrin (500 µg/kg BW/day and 5000 µg/kg
BW/day) groups showed significantly impaired glucose tolerance over high-fat control at
week 11. When insulin levels were measured during glucose tolerance test as a marker of
glucose homeostasis 280 (Figure 4.3G-4.3I), there was a significant effect of diet (p <
0.0001), permethrin (p < 0.05) and interaction effects (p < 0.005) on insulin levels in both
weeks 6 and 11 (Fig. 4.3H and 4.3I). Results of HOMA-IR are shown in Figure 4.4. Both
dietary fat and permethrin showed significant effects in HOMA-IR at week 6, 11 & 12.
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Significant interactions were observed at week 6, but not week 11 & 12 (Fig. 4.4B-4.4D).
Overall, these results suggest that permethrin may cause development of insulin
resistance along with high-fat diet.
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Figure 4.3. Effects of permethrin treatment on insulin responsiveness in male C57BL/6J
mice. Insulin tolerance test (ITT, Figure 4.3A-4.3C), glucose tolerance test (GTT, Figure
4.3D-4.3F), insulin level during GTT (Figure 4.3G-4.3I). Mice were treated with either
control or permethrin-containing diet (50, 500, 5000 µg/kg body weight/day) for 12
weeks in each dietary group. Value represent means ± S.E. (n= 4-8). Means with different
letters are significantly different (p < 0.05).
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Figure 4.4. Effects of permethrin on HOMA-IR score in male C57BL/6J mice. HOMAIR score was calculated during adaptation period, week 6, 11 and 12 with HOMA-IR
calculator. Mice were treated with either control or permethrin-containing diet (50, 500,
5000 µg/kg body weight/day) for 12 weeks in each dietary group. Value represent means
± S.E. (n= 4-8). Means with different letters are significantly different (p < 0.05).
4.3.4 Effects of permethrin on serum markers
Results of serum analyses are shown in Table 4.3. There were significant effects
of diet on insulin (p < 0.0001), glucose (p = 0.0003), leptin (p < 0.0001) and cholesterol
(p <0.0001), but not on free fatty acid or TG levels. Overall, there was a significant effect
of permethrin treatment on insulin (p = 0.0487), glucose (p = 0.0099), leptin (p < 0.0001),
TG (p = 0.0357) and cholesterol (p = 0.0132), but not on non-esterified fatty acids. There
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was a significant interaction between dietary fat and permethrin treatment on glucose (p =
0.0011), leptin (p < 0.0001) and cholesterol (p = 0.015). In high-fat dietary groups,
permethrin treatment at 5000 µg/kg BW/day significantly increased blood level of
glucose (p = 0.0033) and leptin (p < 0.0001) than high-fat control. Permethrin treatment
at 500 µg/kg BW/day significantly increased blood cholesterol levels than control in
high-fat diet groups (p = 0.0181). However, permethrin had no significant effects on any
serum parameters tested in low-fat dietary groups.
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Table 4.3. Effects of permethrin and dietary fat on serum parameters in male C57BL/6J mice
Low-fat

High-fat
p-value

Permethrin doses

Permethrin doses

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Dietary fat

Perm

×

Insulin
(ng/mL)

0.77±0.11

0.86±0.29

1.43±0.48

1.31±0.08

2.05±0.34

3.76±0.47

2.89±0.35

3.01±0.64

<.0001

0.0487

n.s.

Glucose
(mg/dL)

162.8±7.9b

159.6±10.7b

168.3±15.3b

147.6±13.0b

178.2±17.8b

150.4±14.3b

207.3±5.7ab

260.1±13.3a

0.0003

0.0099

0.0011

Leptin
(ng/mL)

4.9±1.00c

6.71±1.07c

3.91±0.62c

3.17±0.45c

14.4±3.7b

35.54±4.41b

62.40±11.81a

62.97±5.94a

<.0001

<.0001

<.0001

NEFA
(mEq/L)

1.20±0.08

1.21±0.14

1.46±0.11

1.10±0.02

1.06±0.09

1.20±0.14

1.13±0.08

1.28±0.04

n.s.

n.s.

n.s.

TG
(mmol/L)

0.77±0.06

0.87±0.10

0.93±0.13

0.74±0.03

0.62±0.04

0.83±0.05

0.91±0.05

1.06±0.11

n.s.

0.0357

n.s.

Cholesterol
(mg/dL)

162±9c

156±14c

169±10bc

142±13c

171±15bc

167±18bc

246±19a

229±12ab

<.0001

0.0132

0.015

Mice were treated with three doses of permethrin (50, 500, & 5000 µg/kg body weight/day). Values represent means ± SE (n=5-8). Means with different superscripts within the
same row are significantly different at p < 0.05. Abbreviations: n.s., not significant; TG, triglyceride; NEFA, non-esterified fatty acid. Perm, permethrin; ×, interaction.
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4.3.5 Effects of permethrin on markers of epididymal white adipose tissue
The AMP-activated protein kinase (AMPK) plays important role in regulating
cellular energy metabolism as well as glucose and lipid metabolisms 281. Based on
previous report that permethrin potentiate adipogenesis via inhibiting the activation of
AMPK 201, we have measured AMPKα activities in epididymal adipose tissue (Fig. 4.5).
There was a significant effect of diet on phosphorylated AMPKα and AMPKα as well as
ratio of pAMPKα/AMPKα (p < 0.05, Fig. 4.5A-4.5C), while significant permethrin
effects were observed on pAMPKα and pAMPKα/AMPKα without any significant
interactions for all.
As one of main down-stream targets of AMPK, ACC gets phosphorylated at Ser
79 (pACC) resulting in inactivation of ACC 282, 283 (Fig. 4.5D-4.5F). There was a
significant effect of diet (p = 0.0044) and permethrin treatment (p = 0.0215) without
interaction on pACC level (Figure 4.5D). For ACC level, there was a significant effect of
diet (p < 0.0001) without any effects of permethrin or interaction (Fig. 4.5E). There was a
significant effect of permethrin (p = 0.0087) without dietary and interaction effects on
pACC/ACC ratio (Fig. 4.5F). Calcium/calmodulin-dependent protein kinase kinase-beta
(CaMKK) is one of upstream regulator of AMPK 284. The current results showed
permethrin significantly decreased the protein level of CaMKK, while no effects of
dietary fat and interaction were observed (Fig. 4.5H).
Glucose transporter-4 (GLUT4) is the major glucose transporter responsible for
insulin-stimulated glucose uptake expressed in both adipose tissue and muscle 285. There
were significant effects of diet and permethrin without interaction on GLUT4 gene
expression in adipose tissue (Fig. 4.5I). Next, we measured the expression of tumor
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necrosis factor-α (TNFα), as it is an important inflammatory cytokine that plays key role
in obesity induced insulin resistance in type 2 diabetes 286. Significantly higher levels of
TNFα expression were observed by both diet and permethrin with interaction in adipose
tissue (Fig. 4.5J). Sterol regulatory element-binding protein 1 (SREBP1) is another
important regulator of adipogenesis 287. Permethrin significantly increased SREBP
without effects of diet or interaction (Fig. 4.5K). We also tested CD36 (regulates fatty
acid update) and acyl CoA: diacylglycerol acyltransferase 1 and 2 (DGAT, catalyze
mammalian triacyglycerol synthesis and lipid droplet formation), however, there were no
effects of diet or permethrin for these markers (data not shown)
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288, 289

.
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Figure 4.5. Effects of permethrin treatment on molecular targets involved in lipid
metabolism and inflammation in epididymal white adipose tissue in male C57BL/6J
mice. A. Protein levels of phosphorylated AMPKα (pAMPKα); B. AMPKα; C. pAMPKα
to AMPKα ratio; D. Phosphorylated acetyl-CoA carboxylase (pACC); E. Acetyl-CoA
carboxylase (ACC); F. pACC to ACC ratio; and G. Representative pictures. H.
Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ); I, glucose transporter
type 4 (GLUT4); J, tumor necrosis factor-α (TNFα); and K, sterol regulatory elementbinding protein (SREBP1). Mice were treated with either control or permethrincontaining diet (50, 500, 5000 µg/kg BW/day) for 12 weeks in each dietary group. Value
represent means ± S.E. (n= 4-5). Means with different letters are significantly different (p
< 0.05).
4.3.6 Effects of permethrin on the liver
The increase in hepatic gluconeogenesis is believed to play an important role in
the elevation of fasting blood glucose level and pathogenesis of diabetes 290, 291.
Phosphoenolpyruvate carboxykinase (PEPCK) is the key enzyme regulating
gluconeogenesis, as overexpression of hepatic PEPCK gene in mice lead to the
development of non-insulin-dependent diabetes mellitus 290, 291. There was a significant
effect of diet (p = 0.006) and permethrin (p = 0.0149) with significant interaction on
PEPCK level (Fig. 4.6A). Permethrin treatment at 500 (p = 0.0056) and 5000 µg/kg (p =
0.0431) significantly elevated PEPCK gene expression in the high-fat diet groups.
However, no significant difference was found in the low-fat diet group.
PPARα is expressed principally in liver where it play important role in regulating
fatty acid oxidation 292. There was a significant effect of permethrin, but not diet or
interaction, on suppressing PPARα gene expression in liver (Figure 4.6B).
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Figure 4.6. Effects of permethrin treatment on molecular targets involved in glucose and
lipid metabolism in the liver of male C57BL/6J mice. A. Phosphoenolpyruvate
carboxykinase (PEPCK); B. Peroxisome proliferator-activated receptor-α (PPARα). Mice
were treated with either control or permethrin-containing diet (50, 500, 5000 µg/kg
BW/day) for 12 weeks in each dietary group. Value represent means ± S.E. (n= 3-5).
Means with different letters are significantly different (p < 0.05).

4.3.7 Effects of permethrin on glucose metabolism in gastrocnemius skeletal muscle
In addition to adipose tissue, GLUT4 is expressed in the muscle, particularly
GLUT4 level in slow muscle fibers play significant role in overall glucose metabolism
293, 294

. There was a significant effect of dietary fat (p < 0.0001) and permethrin (p =

0.0064) without interaction on GLUT4 gene expression in gastrocnemius muscle (Fig.
4.7A).
Pyruvate dehydrogenase kinase (PDK) plays key role in phosphorylation and
inactivation of pyruvate dehydrogenase complex, which controls glucose oxidation 295.
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Insulin suppresses the PDK4 gene expression in normal state. However, this effect is
reduced in insulin resistance state resulting in increased PDK4 gene expression 296. There
was a significant effect of diet (p < 0.0001) and permethrin (p = 0.0226) without
interaction on PDK4 gene expression in the muscle (Fig. 4.7B).

Figure 4.7. Effects of permethrin treatment on gene expression regulating glucose
metabolism in gastrocnemius skeletal muscle of male C57BL/6J mice. A. Glucose
transporter type 4 (GLUT4); B. pyruvate dehydrogenase kinase 4 (PDK4). Mice were
treated with either control or permethrin-containing diet (50, 500, 5000 µg/kg BW/day)
for 12 weeks in each dietary group. Value represent means ± S.E. (n= 4-5).

4.4 Discussion
The current study showed that daily administration of permethrin, at dose below
NOEL, can potentiate high-fat diet induced weight and fat mass gains as well as altered
insulin resistance in male mice, while no effects of permethrin were observed when it
was supplemented in low-fat diet in these animals. To our knowledge, this is the first in
vivo study reporting the potential role of permethrin in obesity and type 2 diabetes, along
with dietary fat interaction.
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AMPK serves as the intracellular energy gauge and is activated when intracellular
ATP production decreases to provide energy. In addition, AMPK can also be activated by
Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) and serine/threonine
kinase 11 (STK11), also known as liver kinase B1 (LKB1) 297. The current results
showed that permethrin might target AMPK in adipocytes and are consistent with
previous report that permethrin alters adipogenesis via AMPK-mediated mechanisms in
3T3-L1 adipocytes in vitro 201. In addition, three other insecticides were reported to
promote fat accumulation via AMPK-mediated mechanism 23, 216, 298.
Moreover, the current study shows that permethrin, along with high-fat diet,
worsened insulin resistance. The link between exposures to organochlorine and
organophosphorus insecticides and increased risk of development of type 2 diabetes, in
both humans and animals, have been reported previously 6, 24, 83, 90, 91, 95, 96, 299. In addition,
two type I pyrethroids (allethrin and prallethrin) were previously reported to increase
blood glucose level in male subjects 85. Another study reported male pesticide sprayers
exposed to pyrethroid mixture have higher prevalence of developing prediabetes 122.
Similarly, Wang et al. reported that increased the risk of diabetes among pyrethroid
pesticide factory workers 300. Animal studies have consistently reported the link between
exposure to pyrethroids and the disturbance of glucose homeostasis 181, 182, 184, 185.
Exposures to cismethrin, decamehthrin, and deltamethrin were previously reported to
increase blood glucose level in rats 182, 184, 185. Elevated level of insulin was found in the
serum of male rat exposed to α-cypermethrin 181.
In addition to animal studies, our group reported in vitro that permethrin reduced
insulin-stimulated glucose uptake by decreasing the activation of AKT at Thr308 in
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C2C12 muscle cells 201. AKT plays significant role in inducing glucose uptake by
stimulating GLUT4 translocation to the plasma membrane 301. In this study, we did not
measure the activity of AKT. However, we measured the gene expression of GLUT4 in
adipose tissue and muscle. The current results indicated that permethrin treatment
significantly decreased the gene expression of GLUT4 in both adipose tissue and muscle.
Previously, developmental exposure to the pyrethroid insecticide deltamethrin was
reported to decrease adipose tissue GLUT4 gene expression in male mice offspring 302.
Neonicotinoid insecticide imidacloprid was also reported to decrease muscle GLUT4
gene expression in mice fed with high-fat diet 134. Thus, we suspect permethrin may
cause insulin resistance via influencing AKT signaling and GLUT4 gene expression. In
addition, we found increased TNFα gene expression in adipose tissue by permethrin
treatment. TNFα is one of the major factors in obesity-induced insulin resistance 286. It is
known that TNFα can cause insulin resistance by increasing serine phosphorylation of
insulin receptor substrate 1 (IRS-1) and inhibit insulin receptor activities 303. Thus, the
effect of permethrin on increased TNFα gene expression may have contributed to
permethrin’s effects on insulin resistance. Previously, it was reported that exposure to
organophosphorus insecticide diazinon increased blood TNFα level 164. Neonicotinoid
insecticide imidacloprid was also reported to increase TNFα gene expression in adipose
tissue of high-fat fed mice 134. In this study, we did not measure the TNFα level in serum
samples. Therefore, it is still not clear whether permethrin caused increased blood TNFα
level in high-fat fed mice. In addition, increased PDK4 gene expression in muscle and
increased PEPCK gene expression in liver by permethrin treatment would further
contributed to altered glucose metabolism in these animals. Additional mechanistic

79

studies on insulin signaling pathway including AKT signaling and insulin-stimulated
GLUT4 translocation will be needed to identify the exact mechanisms of permethrin on
altered insulin responsiveness.
With significant usage of permethrin in a number of commercial products, it is not
surprising that permethrin residues can be frequently found in agricultural products,
household dusts, air, and diet 214, 304-306. In fact, permethrin metabolites were frequently
detected in adults and children urine samples 214, 304, 307. Among various exposure routes,
it is believed that dietary exposure is the main route of exposure to permethrin 214, 304.
Once absorbed, permethrin is rapidly metabolized by esterases and oxidases in the liver
214, 304, 308, 309

. Biological elimination half-life of permethrin ranged from 5 hours to 56

hours when administered orally 1 mg/kg in rat 310. Due to highly lipophilic characteristic,
however, permethrin is rather resistant to metabolism and may accumulate in adipose
tissue 214.
It is also important to point out that permethrin doses used in the current study are
relatively low (lower than NOEL); ADI (50 µg/kg BW/day) 272 and NOEL (5000 µg/kg
BW/day) 273. Thus, the results of the current study will be significant in that even at
exposures that are considered ‘safe’, there may be significant effects on glucose and lipid
metabolism in animals and humans when there are additional factors present, such as diet
or other environmental contaminants.
Another potential mechanism is that permethrin along with its metabolites may
serve as endocrine-disrupting agents, which contribute to lipogenesis 309, 311. The major
permethrin metabolites include, but not limited to, 3-phenoxybenzoic acid (free and
glucuronide and glycine conjugates), the sulfate conjugate of 4’-hydroxy-3-
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phenoxybenzoic acid, the sulfate conjugate of 2’hydroxy-3-phenoxybenzoic acid (from
cis-permethrin only), the trans- and cis-dichlorovinyldimethylcyclopropane-carboxylic
acids (free and glucuronide conjugates), and the 2-trans- and 2-cis-hydroxymethyl
derivatives of each of the aforementioned trans and cis acids (free and glucuronide
conjugates) 16, 308. Cleavage and oxidation are believed to be the two major forms of
metabolic reaction for permethrin. Most of the metabolic reaction begins at the terminal
aromatic ring of the phenoxybenzyl moiety as well as the germinal dimethyl group of the
cyclopropane ring and ends by conjugation 16. It is generally accepted that cis-permethrin
is harder to metabolize than trans-permethrin 312. McCarthy et al found that two
permethrin metabolites, 3-phenoxybenzyl alcohol 3-(4-hydroxy-3-phenoxy) benzyl
alcohol, and 3-phenoxybenzaldehyde possess estrogenic activity, which is about 105 less
than that of 17β-estradiol 309.
We have estimated doses of permethrin to be added in the diet based on average
dietary intake and weight, although it was apparently that animals consumed higher doses
of permethrin than originally intended (16-44% higher than intended doses, in Method
section). However, no statistical differences were observed for doses of permethrin
delivered to animals between two diets. Thus, any effects of permethrin observed only in
high-fat fed animals still represent the role of dietary fat in permethrin’s biological
function. At this moment, it is not clear how dietary fat contributed to permethrin’s effect
on weight and fat mass gain and insulin resistance. We speculate that dietary fat caused
metabolic changes in these animals, which may have been worsened with permethrin.
Alternatively, since permethrin is highly lipophilic, it is likely that the absorption of
permethrin with high-fat diet would be more efficient than that of low-fat diet. Thus, even

81

though there were no significant differences in permethrin doses administered, there may
be dose-responses due to dietary fat content. Further investigation on the absorption
efficacy of permethrin when delivered orally in the diet and metabolic consequence of
permethrin are needed.
The current results also suggest significant increase of serum cholesterol levels by
permethrin with high-fat diet. Previously, the link between exposures (including
developmental exposure) to organochlorine, organophosphorus, and carbamate
insecticides and increased cholesterol level in both humans and animals were reported 107,
140, 147, 154-156, 170, 180, 313

. In addition, pyrethroid insecticides, cypermethrin and

deltamethrin, were reported to increase blood cholesterol level in mice and rat 149, 181, 185.
In particular, cypermethrin was reported to increase VLDL, while decreasing HDL in
mice 149. Similarly, deltamethrin was shown to increase LDL and VLDL, while
decreasing HDL levels in rat 185. One human study, however, reported negative
correlation between chronic exposure to allethrin and prallethrin and blood cholesterol
level in men 85. Therefore, exposure of pyrethroid insecticides may increase the risk of
hypercholesterolemia. Further human studies are needed to investigate the effects of
pyrethroid insecticides on alteration of blood cholesterol levels.
In summary, the current study suggests the potential role of permethrin and
dietary fat in development of excessive weight gain and insulin resistance in male mice.
This is the first animal study determining the potential role of daily exposure to relatively
low levels of permethrin in development of obesity and type 2 diabetes. Although it is not
clear how permethrin elicit these effects, it is suggested that permethrin might target
AMPK, fatty acid oxidation and insulin-sensitive glucose transporters. Based on the
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current study, further studies are needed to identify the molecular targets of permethrin as
well as effects of permethrin in female mice.
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CHAPTER 5
PERMETHRIN ALTERS GLUCOSE METABOLISM WITH HIGH-FAT DIET
AND DECREASES VOLUNTARY ACTIVITIES IN FEMALE C57BL/6J MICE
5.1 Introduction
Permethrin [(±)-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2
dimethylcyclopropanecarboxylate] is a synthetic insecticide that belongs to the pyrethroid
family, which possesses structural resemblance to the natural pyrethrins. Developed in
1970s, synthetic pyrethroids demonstrate significantly improved photostability than its
natural counterparts without sacrificing its potent insecticidal activities and low acute
mammalian toxicity 18. The use of pyrethroids has dropped slightly since 1997 27, but
they are still the second largest insecticide class current on the market, accounting for
16% of the global insecticides sales in 2015 47.
In mammals, exposure to permethrin can produce syndromes of tremor and
hyperactivities 34, 42, 43. When orally exposed, permethrin can be quickly absorbed into the
blood and subject to hydrolysis and degradation by esterases and cytochrome P450dependent monooxygenases in the liver and other tissues with an elimination half-life of
approximately 12h 18, 314, 315. Permethrin is highly lipophilic, thus less likely to
contaminate ground water. When exposed in the environment, permethrin can be rapidly
broken down by microorganism or sunlight 316. An experiment applying permethrin
indoors near a window found that only 60% of permethrin remained after 20 days when it
was exposed to daylight 316. The half-life of permethrin in soil under aerobic laboratory
conditions was reported to be less than 28 days 16.
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Based on these characteristics, permethrin is one of the most widely-used
synthetic pyrethroid insecticides in agricultural, veterinary, medical and household
setting 310. Products containing permethrin may be used on food and feed crops, on
livestock, pets and/or on places where food is handled (e.g. restaurants) 33. Other
applications of permethrin include in public health mosquito control programs, human
head lice control, and/or in clothing. Thus, human exposure to permethrin is quite likely.
Previously, some human and animal studies have found that exposure to
pyrethroid insecticides can disturb glucose and lipid metabolisms and increase the risk of
obesity and type 2 diabetes. 10, 84, 85, 122, 181-183, 185. Our laboratory also demonstrated that
exposure to permethrin can increase weight gain and insulin resistance in high-fat fed
male mice as shown in the previous chapter. However, the effects of permethrin in
females with high-fat diet induced obesity and insulin resistance have not been
determined. In fact, some studies suggested exposure to insecticides may have sexselectively influence body weights as well as glucose and lipid metabolisms 137, 140, 144, 180.
Thus, the purpose of this study was to investigate the effects of permethrin, along with
dietary fat, on glucose and lipid metabolisms in female C57BL/6J mice.

5.2 Materials and methods

5.2.1 Materials

Permethrin (98%, mixture of cis and trans isomers) and HDL/LDL Quantitation
kit were purchased from Sigma Aldrich Co. (St. Louis, MO). Insulin (human
recombinant) was acquired from Novo Nordisk Inc. (Princeton, NJ). D-glucose solution
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(50%) was obtained from Hospira Inc. (Lake Forest, IL). Glucose, cholesterol and TG kit
were from Thermo Scientific (Rockford, IL). Insulin ELISA kit was purchased from
Mercodia (Winston Salem, NC). Leptin ELISA kit was from R&D systems (Minneapolis,
MN). Free fatty acid assay kit was purchased from Cell Biolabs Inc. (San Diego, CA).
Pierce BCA protein assay kit (Thermo scientific, Rockford, IL) was used for protein
quantification. Rabbit antibodies of phosphorylated phosphoinositide-dependent kinase
(pPDK), phosphorylated protein kinase B at threonine 308 (pAkt Thr308) and serine 473
(pAkt Ser473), Akt and Glucose transporter 4 (GLUT4) were purchased from Cell
Signaling Technology (Danvers, MA). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Horseradish peroxidase-conjugated anti-rabbit secondary antibody was obtained from
Cell Signaling Technology (Danvers, MA). Other chemicals were either purchased from
Sigma-Aldrich (St. Louis, MO) or Fisher Scientific (Waltham, MA).

5.2.2 Animals and diet

All animal care and procedures were approved by the Institutional Animal Care
and Use Committee of the University of Massachusetts Amherst. Female C57BL/6J mice
were purchased from the Jackson’s Laboratory (Bar Harbor, ME) at 3 week of age and
were housed two mice per cage with a 12h light-dark cycle in a temperature and humidity
controlled room. Semi-purified AIN-93-based diet from Harlan Laboratories (TD94048
for low-fat and TD07518 for high-fat diets, Madison, WI) in powdered form were used.
Permethrin was dissolved in soybean oil and mixed with other ingredients in diet. Diet
and water were given to mice ad libitum throughout the experiment period except when
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fasting was conducted prior to glucose measurement. After a week of adaptation with
low-fat diet (4 w/w % fat), all mice were given a baseline test for insulin tolerance in the
2nd week of adaptation and glucose tolerance test in the 3rd week of adaptation. Then,
animals were then randomly divided into two dietary groups: low-fat diet (4 w/w % fat)
and high-fat diet group (20 w/w % fat). Within each dietary group, control diet (without
permethrin) and three different doses of permethrin-containing diet were given to mice
for 12 weeks. In the low-fat diet groups, permethrin concentration in diet is 0.26, 2.6, and
26 µg/g diet to deliver 50, 500 and 5000 µg/kg BW/day; in the high-fat diet group,
permethrin concentration in diet is 0.36, 3.6 and 36 µg/g diet to deliver 50, 500 and 5000
µg/kg BW/day. Body weight and food intake were measured weekly. Food intake was
measured as the total food intake per cage. Estimated permethrin intake in low-fat diet
fed animals were 33 ± 1 µg/kg BW/day, 334 ± 2 µg/kg BW/day and 3387 ± 93 µg/kg
BW/day for 50 µg/kg BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day,
respectively. Estimated permethrin intake in high-fat diet fed animals were 31 ± 2 µg/kg
BW/day, 374 ± 11 µg/kg BW/day and 3491 ± 100 µg/kg BW/day for 50 µg/kg BW/day,
500 µg/kg BW/day and 5000 µg/kg BW/day, respectively. There were no significant
differences on 3 permethrin doses delivered between low- vs. high-fat diets. At the end of
the study, mice were fasted for 4 hours and sacrificed by CO2 asphyxiation. Blood was
immediately collected by cardiac puncture and then sera were collected by centrifugation
at 3,000 g for 20 mins at 4 °C. Internal organs (liver, heart, pancreas, kidneys, spleen, and
white adipose tissues including epididymal, retroperitoneal and mesenteric fat pads) were
weighed at sacrifice and kept in -80C for further analyses.
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5.2.3 Determination of glucose homeostasis

Insulin tolerance test (ITT) was conducted three times during the experiment
(adaptation period, week 4, and week 10). Animals were fasted for 4 hours before test,
tail-vein blood samples were obtained at 0, 15, 30, 60 and 120 minutes after
intraperitoneal injection a bolus of insulin (0.75U/kg BW). Intraperitoneal glucose
tolerance tests (GTT) were conducted in the adaptation period, at week 5 and week 11.
Mice were fasted for 6 h prior to test. A bolus of glucose solution (2 g/kg BW) was
injected into the intraperitoneal cavity, and blood was obtained from the tail end to
measure glucose level at 0, 15, 30, 60, 120 min. Blood samples at 0, 30, 60, 120 min were
also used for testing insulin level based on a method described previously 276. All blood
glucose levels were tested by using a glucometer with test strips (Advocate, Pharma
Supply Inc, Wellington, FL). The areas under the curve (AUC) were calculated using
SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA). HOMA-IR was calculated using
HOMA2 calculator provided by University of Oxford 277.

5.2.4 Voluntary movement measurement (Non-exercise physical activity test)

Voluntary movement (non-exercise physical activity) was measured in week 1
and week 8 by using a method described previously 278, 317. Briefly, individual mouse was
put into a clear cage during the dark cycle(6:00 pm to 6:00 am). Diet and water
(HydroGel, Portland, ME, USA) were provided ad libitum to mice during the
measurement. Total travel distance (m) were recorded by an infrared camera with
LoliTrack Quatro Video Tracking Software Version 1.0 (Loligo Systems, Tjele,
Denmark). Data from early phase (6:00 pm to 8:00 pm) due to adaptation to new
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environment and late phase (4:00 am to 6:00 am) due to sedentary behavior were
excluded. Movement data from 8:00 pm to 4:00 am were used for analysis.

5.2.5 Western blot analysis
Immunoblot was conducted based on a method described previously 278. Briefly,
gastrocnemius skeletal muscle was frozen in liquid nitrogen and ground using a pestle
and mortar. Sample was lysed using radioimmunoprecipitation assay buffer containing
protease & phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL). Sample
lysates were then centrifuged at 12,000g for 20 min at 4 °C. Protein concentration was
determined using Pierce BCA protein assay kit (Thermo scientific, Rockford, IL).
Samples were then separated by sodium dodecyl sulfate−polyacrylamide gel and
transferred to polyvinylidene fluoride membrane (Millipore, Bedford, MA). Visualization
was achieved with an Image Station 4000MM instrument (Carestream Health, New
Heaven, CT) by using Clarity ECL Western blot substrate (Bio-Rad, Hercules, CA) after
incubation with primary and horseradish peroxidase-conjugated secondary antibodies.
The band densities were analyzed using ImageJ software (U.S. National Institutes of
Health). Protein levels were normalized to GAPDH expression.

5.2.6 Statistical analysis

Data were analyzed by PROC MIXED using the SAS software (Version 9.3, SAS
Institute Inc., Cary, NC, USA). Body weight (Figure 5.1A) data were analyzed by twoway repeated measure Analysis of Variance (ANOVA) with the slice option in the Least
Square (LS) means statement. All the other results were analyzed by two-way ANOVA
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with LS means statement. The Tukey-Kramer’s method was used for the multiple
comparisons among the experimental groups. Letters (a, b, c, etc.) were used to present
differences between each experimental group if there were significant interactions
between dietary fat and permethrin. p-values less than 0.05 were reported as significant.

5.3 Results
5.3.1 Effects of permethrin on body weight, energy intake and organ weights

Results of body weight and food intake are shown in Fig. 5.1A. Food intake was
presented as the total energy intake over 12-week experimental period (Fig. 5.1B). There
was a significant dietary fat effect on body weight; high-fat fed mice gained 2-fold more
body weight than low-fat fed mice (p < 0.0001). However, no significant permethrin and
interaction effect (dietary fat × permethrin × time) was observed. There was no
significant difference in energy intake between high-fat and low-fat groups; 42.48-45.11
KJ/mouse/day in low-fat vs. 42.39-44.74 KJ/mouse/day in high-fat fed animals. There
was no effect of permethrin treatment on energy intake.
Dietary fat significantly decreased the weight of liver, heart, spleen, and kidney,
but not pancreas (Table 5.1). However, no significant effects of permethrin nor
interaction effect were observed on any of the organ weights. Mice fed high-fat diet
showed significantly higher adipose tissue weight than low-fat counterparts (1.8 fold, p <
0.0001 for all), while no permethrin and interaction effects were observed for all adipose
tissue weights.
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Figure 5.1. Effects of permethrin treatment on body weight (A) and energy intake (B) in
female C57BL/6J mice. Low-fat or high-fat diet without or with permethrin [50, 500,
5000 µg/kg body weight (BW)/day] were given to mice ad libitum for 12 weeks. (A)
Blank symbols, low-fat fed mice; Filled symbols, high-fat fed mice. Circles, control; Uptriangles, 50 µg/kg BW/day; Down-triangles 500 µg/kg BW/day; Squares, 5000 µg/kg
BW/day. Values represent means ± S.E. (Figure 1A, n= 5-6; Figure 1B, n =3). Means
with different letters are significantly different (p < 0.05).

91

Table 5.1. Effects of permethrin and dietary fat on organ weights (% of body weight) in female C57BL/6J mice
Low-fat

High-fat
p-value

Permethrin doses

Permethrin doses

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Liver

4.15±0.19

4.18±0.08

3.84±0.16

4.05±0.10

3.42±0.23

3.44±0.22

3.63±0.13

3.62±0.07

Dietary
fat
< .0001

Heart

0.45±0.01

0.49±0.02

0.43±0.04

0.48±0.04

0.34±0.08

0.38±0.01

0.40±0.03

0.32±0.06

Spleen

0.38±0.02

0.34±0.02

0.34±0.02

0.35±0.01

0.31±0.01

0.39±0.06

0.32±0.02

Kidney

1.07±0.01

1.10±0.05

0.99±0.04

1.12±0.08

0.92±0.05

0.97±0.04

Pancreas

0.55±0.04

0.51±0.02

0.41±0.02

0.55±0.07

0.60±0.09

Omental

2.20±0.29

2.63±0.20

3.18±0.21

2.43±0.31

Subcutaneous

2.00±0.25

2.49±0.1

3.34±0.17

Retroperitoneal

0.46±0.07

0.57±0.07

Mesenteric

1.09±0.10

Total

5.75±0.65

Perm

×

NS

NS

0.001

NS

NS

0.32±0.01

0.0002

NS

NS

0.95±0.02

0.91±0.03

0.0002

NS

NS

0.56±0.05

0.50±0.05

0.52±0.04

NS

NS

NS

4.62±0.51

4.36±0.43

4.59±0.43

4.65±0.42

<.0001

NS

NS

2.64±0.41

5.55±0.72

4.87±0.58

5.37±0.66

5.31±0.45

<.0001

NS

NS

0.67±0.08

0.55±0.11

1.09±0.15

1.10±0.06

1.21±0.11

1.16±0.12

<.0001

NS

NS

1.43±0.13

1.49±0.17

1.13±0.12

1.99±0.31

1.94±0.25

2.09±0.09

2.06±0.26

<.0001

NS

NS

7.12±0.53

8.68±0.52

6.75±0.94

13.25±1.65

12.26±1.26

13.25±1.17

13.18±1.17

<.0001

NS

NS

Adipose tissue

Values represent means ± SE (n=5-6). Abbreviations: NS, not significant;, Perm, permethrin; ×, interaction.
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5.3.2 Permethrin treatment significantly decreased voluntary movement (nonexercise physical activity) along with high-fat diet
Results of voluntary movement as travel distance change between week 1 and
week 8 (%) are shown in Fig. 5.2. There was a significant dietary fat effect on voluntary
activities (2.3 fold, p = 0.0186). High-fat fed mice showed significantly decreased
voluntary activities than low-fat fed mice. There was a significant effect of permethrin (p
= 0.0069). Permethrin treatment at 50 and 5000 µg/kg BW/day significantly decreased
voluntary activities over control (3.7 fold and 3.5 fold, respectively, p < 0.05). No
interaction effect of permethrin and dietary fat was found.
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Figure 5.2. Effects of permethrin on voluntary movement (non-exercise physical activity
test) in female C57BL/6J mice. Low-fat or high-fat diet without or with permethrin [50,
500, 5000 µg/kg body weight (BW)/day] were given to mice ad libitum for 12 weeks.
Voluntary movement was measured in week 1 and week 8 from 6:00 pm to 6:00 am
during dark circle. Results are presented as travel distance change between week 1 and
week 8. Diet and water (HydroGel, Portland, ME, USA) were provided ad libitum to
mice during the measurement. Total travel distance (m) were recorded by an infrared
camera with LoliTrack Quatro Video Tracking Software Version 1.0 (Loligo Systems,
Tjele, Denmark). Movement data from 8:00 pm to 4:00 am were used for analysis.
Values represents means ±S.E. (n=5-6).
5.3.3 Effects of permethrin on serum markers of glucose and lipid metabolism
Results of serum analyses are shown in Table 5.2. Dietary fat showed significant
effects on increasing insulin (1.6 fold), leptin (2.8 fold), cholesterol (1.1 fold) and high
density lipoprotein cholesterol (1.2 fold) levels, but failed to show any significant effect
on glucose, free fatty acids, triglycerides, and low-density lipoprotein cholesterol levels.
Permethrin treatment significantly increased blood insulin (p = 0.0106) and glucose

94

levels (p = 0.0075) but failed to show any significant effect on leptin, free fatty acids,
triglycerides, cholesterol, high-density lipoprotein and low-density lipoprotein cholesterol
levels. There were no significant interactions between diet and permethrin on all serum
markers tested except insulin. Permethrin treatment at 5000 µg/kg BW/day significantly
increased insulin level than control in high-fat dietary groups (1.9 fold), but not in low-fat
dietary groups.
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Table 5.2. Effects of permethrin and dietary fat on serum parameters in female C57BL/6J mice
Low-fat

High-fat

Permethrin doses

p-value

Permethrin doses

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Control

50 µg/kg

500 µg/kg

5000 µg/kg

Dietary
fat

Perm

×

Insulin
(ng/mL)

1.27±0.22b

1.06±0.11b

1.27±0.15b

1.11±0.09b

1.47±0.11b

1.21±0.10b

2.04±0.34ab

2.80±0.47a

0.0002

0.0106

0.01

Glucose
(mg/dL)

167.0±9.4

197.0±12.1

225.6±14.5

176.6±16.2

170.8±14.4

151.4±12.5

198.0±7.3

196.1±13.7

NS

0.0075

NS

Leptin
(ng/mL)

14.60±3.83

18.80±4.35

17.85±5.39

15.24±6.86

48.80±8.66

36.29±7.58

57.53±9.62

48.83±9.45

<0.0001

NS

NS

FFA
(mEq/mL)

844±166

916±64

1051±170

904±160

935±146

853±335

973±115

590±188

NS

NS

NS

TG
(mmol/L)

0.43±0.07

0.49±0.10

0.67±0.06

0.43±0.12

0.43±0.05

0.42±0.11

0.42±0.07

0.38±0.06

NS

NS

NS

Cholesterol
(mg/dL)

126±5

155±11

155±10

149±19

151±8

162±8

163±8

173±6

0.0234

NS

NS

HDL-C
(mg/dL)

109±4

117±10

113±8

116±3

115±12

129±7

132±9

145±8

0.0064

NS

NS

LDL-C
(mg/dL)

26±2

26±4

27±3

29±7

28±4

26±2

28±4

19±2

NS

NS

NS

Values represent means ± SE (n=5-6). Means with different superscripts within the same row are significantly different at p < 0.05. Abbreviations: NS, not significant; FFA,
free fatty acids; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Perm, permethrin; TG, triglycerides; ×, interaction.
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5.3.4 Effect of permethrin on glucose homeostasis
To measure the effects of permethrin on glucose homeostasis, insulin tolerance
test (ITT), glucose tolerance test (GTT) with insulin measurement, and HOMA-IR
calculations were completed. There were no significant effects of dietary fat or
permethrin on insulin responsiveness measured by ITT, GTT, insulin level, or HOMA-IR
during adaptation period (Fig. 5.3A, 5.3D, 5.3G, and Fig. 5.4A). In week 4 & 10, high-fat
fed animals showed significantly increased insulin resistance compared to low-fat fed
animals (1.2 fold for both week 4 & 10, respectively, p < 0.0001 for both week, Fig. 5.3B
& 5.3C). Permethrin treatment significantly decreased insulin responsiveness as
demonstrated by ITT in week 10 (1.1 fold, p = 0.0473, Fig. 5.3C). However, no
significant interaction between dietary fat and permethrin was found in week 4 & 10.
In week 5 & 11, there was a significant effect of dietary fat (p = 0.0008 for week
5 and p < 0.0001 for week 11) for GTT (Fig. 5.3E & 5.3F). Permethrin showed
significant effect on increasing glucose tolerance in week 11 (1.2 fold, p = 0.0369).
Permethrin treatments at 5000 µg/kg BW/day significantly increased glucose tolerance
compared to control (1.2 fold, p = 0.0383). However, no significant interaction was
found.
For insulin level during GTT, there was a significant effect of dietary fat on
increasing blood insulin in week 5 & 11 (1.5 and 2.0 fold for week 5 and week 11,
respectively, p < 0.0001 for both week 5 & 11, Fig. 5.3H & 5.3I). There was a significant
effect of permethrin on increasing blood insulin level (1.5 fold, p = 0.0271) and
interaction effect (p = 0.0344) in week 11 only (Fig. 5.3I). In high-fat diet, permethrin
treatment at 5000 µg/kg BW/day significantly increased insulin level than control (2.0
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fold, p =0.0056). However, no significant effect of permethrin was observed in low-fat
dietary groups on insulin level during GTT.
To evaluate overall influence of permethrin on glucose homeostasis, we
calculated HOMA-IR (Fig. 5.4). There was a significant effect of dietary fat on
increasing HOMA-IR in week 5, 11 & 12 (1.3, 1.8, & 1.5 fold, p = 0.0096, 0.0003, &
0.0015, respectively). There was a significant effect of permethrin (p = 0.0116) on
increasing HOMR-IR (1.2 fold, p = 0.0268) and interaction (p = 0.0268) in week 12 only.
Permethrin treatment at 5000 µg/kg BW/day significantly increased insulin resistance in
high-fat dietary group compared to control (p = 0.0138). However, no significant effect
of permethrin was found in low-fat dietary groups.
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Figure 5.3. Effects of permethrin treatment on insulin responsiveness in female
C57BL/6J mice. Low-fat or high-fat diet without or with permethrin [50, 500, 5000
µg/kg body weight (BW)/day] were given to mice ad libitum for 12 weeks. Insulin
tolerance test (ITT, Figure 3A-C), glucose tolerance test (GTT, Figure 3D-F), insulin
level during GTT (Figure 3G-I). Values represent means ± S.E. (n= 4-6). Means with
different letters are significantly different (p < 0.05).
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Figure 5.4. Effects of permethrin on homeostasis model assessment - insulin resistance
(HOMA-IR) score in female C57BL/6J mice. Low-fat or high-fat diet without or with
permethrin [50, 500, 5000 µg/kg body weight (BW)/day] were given to mice ad libitum
for 12 weeks. HOMA-IR score was calculated during adaptation period, week 6, 11 and
12 with HOMA-IR calculator. Values represent means ± S.E. (n= 4-6). Means with
different letters are significantly different (p < 0.05).
5.3.5 Permethrin treatment significantly decreased the activation of AKT pathway
in muscle
Skeletal muscle plays significant role in glucose uptake, which accounts for up to
75% of insulin-dependent glucose uptake 52. In this study, we measured several key
regulators in insulin-stimulated glucose uptake pathway, including Akt,
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phosphoinositide-dependent kinase (PDK1), and GLUT4. Our results showed that
permethrin and dietary treatment showed no significant difference in changing the protein
level of Akt and pAkt Ser473. However, permethrin treatment significantly decreased
pAkt Thr308 (1.1 fold, p = 0.0386, Fig 5.5A) and pAkt Thr308 to Akt ratio (p = 0.0176,
Fig. 5.5D). Phosphorylated PDK1 (pPDK1) is one of the upstream markers of Akt.
Dietary fat showed no significant effect on pPDK1 level. Permethrin treatment had a
significant effect of decreasing pPDK1 (p = 0.0245). There was also a significant
interaction of dietary fat and permethrin on pPDK1 level (p = 0.0122, Fig. 5.5F).
Permethrin treatment at 5000 µg/kg significantly decreased pPDK1 in high-fat diet
treatment group compared to high-fat control (2.1 fold, p = 0.0242). GLUT4 is the major
glucose transporter in skeletal muscle, which plays significant role in mediating whole
body glucose homeostasis 294. Permethrin treatment significantly decreased GLUT4
protein level in muscle (1.3 fold, p = 0.0078, Fig. 5.5G). However, no dietary effect and
interaction effect was observed. Taken together, these results showed that permethrin
may target Akt signaling pathway to induce insulin resistance.
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Figure 5.5. Effects of permethrin treatment on molecular targets involved in insulin
signaling pathway in gastrocnemius skeletal muscle of female C57BL/6J mice. Low-fat
or high-fat diet without or with permethrin [50, 500, 5000 µg/kg body weight (BW)/day]
were given to mice ad libitum for 12 weeks. A. Protein levels of phosphorylated Akt
(pAkt) Thr308; B. pAkt Ser473; C. Akt; D. pAkt Thr308 to Akt ratio; E. pAkt Ser473 to
Akt ratio; F. phosphorylated phosphoinositide-dependent kinase-1 (PDK1); and G.
Glucose transporter 4 (GLUT4). Values represent means ± S.E. (n= 4-6). Means with
different letters are significantly different (p < 0.05).
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5.4 Discussion
This is the first report to investigate the potential link between permethrin
exposure and dietary fat on development of obesity and type 2 diabetes in female mice.
The current results show that permethrin potentiated high-fat diet induced insulin
resistance without significant induction of weight gain in C57BL/6J mice. This strain of
mice is known to develop obesity and insulin resistance with high-fat diet 318. High-fat
diet caused significant weight gain and worsened insulin resistance compared to low-fat
diet fed animals without any additional caloric intake in the current study. Permethrin did
not have any effect on weight gain in this model. However, permethrin significantly
worsened the insulin resistance caused by high-fat diet, while no effects of insulin
resistance were observed with permethrin in low-fat diet. The actual doses of permethrin
consumed were similar in both low- and high-fat diets, thus we do not think the different
effects of permethrin on insulin resistance in low vs. high-fat diet were due to different
doses of permethrin delivered. Currently, it is not clear how permethrin worsened highfat diet induced insulin resistance in this model. It is possible, although, that due to highly
lipophilic characteristics of permethrin, absorption may be more efficient with high
dietary fat compared to that of low-fat diet. In fact, acute oral toxicity studies found that
permethrin is much more toxic when dissolved in oil than other vehicles or its undiluted
form 18.
The current results showed that permethrin significantly increased blood insulin
and glucose levels, which indicated increased risk of type 2 diabetes. Generally, the
maximal level of permethrin was reached within 4h after oral administration and then
cleared from plasma with a elimination half-life of approximately 12h 314. In addition, the
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metabolic rate of permethrin in mammals also depends on different tissues and
stereochemical configurations of permethrin. In this study, we used mixtures of cis and
trans isomers of permethrin. Both the cis and trans isomers of permethrin were quickly
metabolized in internal organs and tissues including the liver, kidney, muscle, spleen
except fat, where the cis isomer was found to be much more difficult to eliminate with an
estimated half-life of 12 days 315. Major metabolites of permethrin mainly include 3phenoxybenzoic acid (free and glucuronide and glycine conjugates) and the trans- and
cis-dichlorovinyldimethylcyclopropane-carboxylic acids (free and glucuronide
conjugates) 16. The metabolites of permethrin were found to be of lower toxicity than the
parent compound and are readily excreted 18, 315.
The current results showed that there was a significant effect of permethrin on
decreasing voluntary activities of mice (p = 0.0069). It is known that pyrethroids can
target neurons and influence physical activities in anthropods as well as mammals 319-322.
It was previously shown that daily intraperitoneal injection of deltamethrin, at 8.3-41.5
mg/kg body weights for 1-28 days, significantly decreased locomotive activity in mice
321

. A study reported that permethrin is more easily accumulated in the nervous system

than plasma due to its lipophilic activity 314. The maximum amounts of permethrin in
nervous system (e.g. cerebellum, hippocampus, caudate putamen, frontal cortex,
hypothalamus, and sciatic nerve) were about 1.5~7.5 times higher than in plasma after
oral administration 314.
Our results indicated that there was a sex-dependent effect of permethrin on body
weight. Permethrin treatment potentiated high-fat induced weight gain only in male mice
as shown in previous chapter, but not in female mice. Previous studies on
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organophosphorus insecticides and organochlorine insecticides also reported sexselective metabolic disorder caused by insecticides 137, 144, 323. Oral exposure to
organochlorine insecticide, hexachlorobenzene, at 20 & 100 ppm in diet for four weeks,
was reported to increase weight gain only in male rats 137. Neonatal exposure to
organophosphorus insecticide, parathion, increased body weight gain in males, but
decreased body weight gain in female rats at 0.1 mg/kg BW/day 180. Developmental
exposure to organophosphorous insecticide, chlorpyrifos, initiated weight gain only in
male offspring of rats 144. Currently, we have limited knowledge about the sex-dependent
effects of permethrin on weight gain. It is likely that the differences in male and female
endocrine systems might contribute to this sex-dependent effect 324.
Development of insulin resistance is a major symptom for type 2 diabetes. Insulin
acts via insulin receptor by auto-phosphorylation and then phosphorylates insulin
receptor substrate (IRS) 52. The phosphorylated tyrosines in IRS serve as “docking site”
for other proteins that has SH2 (Ser-homology-2) domains (e.g. PI(3)K) and thus regulate
their activities or subcellular locations 52. Alternatively, IRS1 can undergo serine
phosphorylation, which exerts inhibitory effect on insulin signaling 325. Once activated,
IRS can activate phosphoinositide 3-kinase (PI3K), which subsequently phosphorylate
PDK1 and activate protein kinase B (Akt). Activated Akt increases translocation of
glucose transporter 4 (GLUT4) from cytoplasm to plasma membrane to facilitate glucose
uptake 52. Thus, the role of Akt in insulin-stimulated glucose uptake is essential. Akt can
be phosphorylated by PDK1 at Thr308 and by mTORC2 at Ser473 201, 326-328.
Phosphorylation of both sites are required for Akt activation and the phosphorylation of
Ser473 is not dependent upon phosphorylation of Thr308 or vice versa 327. Our results
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showed that permethrin impaired Akt activation by influencing Akt phosphorylation at
Thr308, but not Ser473 in the gastrocnemius skeletal muscle. These results indicated that
permethrin might target upstream of PDK1 to impair glucose uptake. Previously, it was
suggested that permethrin can significantly reduce insulin-stimulated glucose uptake in
C2C12 muscle cells by decreasing pAkt Thr308 via PDK1, but not Ser473 201, which is
consistent with current results. In addition, our results indicated that permethrin might
influence glucose uptake by decreasing GLUT4 protein level in muscle, which is
consistent with results from chapter 4.
Pyrethroid insecticides were previously shown to disturb glucose homeostasis and
potentially increase the risk of diabetes in human and animals 181, 182, 184, 185, 300. This study
demonstrates that exposure to permethrin can induce high-fat diet induced insulin
resistance without any significant influence on weight gain in female mice.
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CHAPTER 6
PERMETHRIN POTENTIATES ADIPOGENESIS IN 3T3-L1 ADIPOCYTES VIA
ALTERATION OF INTRACELLULAR CALCIUM AND ENDOPLASMIC
RETICULUM STRESS
6.1 Introduction

Permethrin, a pyrethroid insecticide, was previously reported to potentiate obesity
and insulin resistance in vivo as shown in previous chapters. In addition, our group also
reported that permethrin can potentiate adipogenesis and insulin resistance in vitro 201.
However, the detailed molecular mechanisms underlying this permethrin-induced
metabolic disorder have not been fully explored. Thus, the purpose of this chapter is to
study the potential mechanism of permethrin-potentiated adipogenesis and insulin
resistance in 3T3-L1 adipocytes.
The neurotoxicity of permethrin in insects as well as in mammals relies on its
ability to bind and delay the closing of voltage sensitive sodium channels, allowing
increased permeability of sodium ions 329. At high oral doses, permethrin can produce
syndromes, such as aggressive sparring, increased sensitivity to external stimuli, tremor,
and prostration 330-332. Low oral doses of permethrin can lead to dose-dependent decrease
in locomotor activities and increase in the sensitivity of startle response to acoustic
stimulus 322.
In addition to sodium channel, pyrethroid insecticides are also known to influence
the function of voltage-sensitive calcium channels, resulting in increased calcium influx
18, 333, 334

. In fact, calcium channel α1 subunits belongs to a multigene family, which is

evolutionarily related to the voltage-sensitive sodium channel gene family 18. Previous in
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vitro and in vivo studies in human and animals have shown that increased intracellular
calcium is linked with augmented obesity, adipogenesis, as well as insulin resistance 335338

. Thus, it is possible that permethrin may potentiate adipogenesis via increasing

intracellular calcium level.
Endoplasmic reticulum (ER) is an important organelle in eukaryotic cells, which
is responsible for protein synthesis, folding and dispatch 259. In addition, ER also plays
important roles for calcium storage, lipid metabolism, steroid hormone production, and
detoxification of endogenous and exogenous compounds339. When there is an
accumulation of unfolded or misfolded protein in the lumen of ER, the cell will activate a
stress signaling pathway that leads to halting of protein translation, degrading unfolded
and/or misfolded proteins, and increasing the manufacture of molecular chaperones
involved in protein folding, which is called unfolded protein response (UPR) or ER stress
339

. Other factors that disrupt normal ER homeostasis, such as lipid accumulation,

calcium depletion, changes in redox or energy status, etc., can also cause ER stress 339.
The aim of UPR is to restore normal ER function; however, prolonged UPR can often
lead to inflammation and programmed cell death 340. Recent study reported that
pyrethroid insecticide deltamethrin can induce ER stress in nerve cells 42. As ER stress is
also linked with obesity, adipogenesis and insulin resistance 259, 339, 341, 342, we therefore
propose that permethrin may potentiate adipogenesis via mediating intracellular calcium
level and ER stress in 3T3-L1 adipocytes.
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6.2 Materials and methods

6.2.1 Materials

Permethrin (98%, mixture of cis and trans isomers) were purchased from Sigma
Aldrich Co. (St. Louis, MO). 3T3-L1 preadipocytes were purchased from American Type
Culture Collection (Manassas, VA). Dubelco’s modified Eagle’s medium (DMEM), fetal
bovine serum (FBS), methylisobutylxanthin, dexamethasone, insulin, dimethyl sulfoxide,
and protease inhibitor cocktail were purchased from Sigma-Aldrich (St. Louis, MO).
Fura-2 in acetoxymethyl (AM) ester and BCA protein assay kit were purchased from
Thermo Fisher Scientific (Agawam, MA).
Radioimmunoprecipitation assay buffer with ethylenediaminetetraacetic acid and
ethylene glycol tetraacetic acid was purchased from Boston Bioproducts (Ashland, MA).
Rabbit antibodies of inositol-requiring enzyme 1 alpha (IRE1α), phosphorylated protein
kinase R-like endoplasmic reticulum kinase (p-PERK), PERK, X-box binding protein 1s
(XBP1s), phosphorylated eukaryotic translation initiation factor 2 alpha (p-eIF2α), eIF2α,
calmodulin (CaM) and goat antibodies of calcium/calmodulin-dependent protein kinase
kinase 2 (CaMKKβ) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit
antibodies of phosphorylated IRE1α (p-IRE1α) were obtained from Abcam (Cambridge,
MA). Rabbit antibodies of phosphorylated insulin receptor substrate 1 Ser307 (p-IRS1
Ser307), binding immunoglobulin protein (BiP), endoplasmic reticulum oxidoreductase 1
alpha (Ero1-Lα) and mouse antibodies of C/EBP homologous protein (CHOP) were
purchased from Cell Signaling Technology (Danvers, MA). Horseradish peroxidaseconjugated anti-rabbit secondary antibody was obtained from Cell Signaling Technology
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(Danvers, MA). Other chemicals were either purchased from Sigma-Aldrich (St. Louis,
MO) or Fisher Scientific (Waltham, MA). High capacity cDNA reverse transcription kit,
real time PCR primers and Taqman gene expression master mix were obtained from
Applied Biosystem (Carlsbad, CA). Other chemicals were either from Thermo Fisher
Scientific (Waltham, MA) or Sigma-Aldrich (St. Louis, MO).

6.2.2 3T3-L1 cell culture

3T3-L1 preadipocytes were cultured according to a method described previously
23

. Briefly, 3T3-L1 preadipocytes were maintained in 5% CO2 at 37˚C with DMEM

containing 10% FBS and 1% penicillin-streptomycin until confluence (day -2). Two days
after confluence, adipocyte differentiation was induced with a mixture of
methylisobutylxanthin (0.5 mM), dexamethasone (1 µM), and insulin (1 µg/mL) in
DMEM containing 10% FBS (Day 0). On day 2, this medium was replaced with DMEM
containing 10% FBS and insulin (1 µg/mL) only. On day 4, cells were treated with
DMEM containing 10% FBS only. On day 4 and thereafter, medium consisting of
DMEM plus 10% FBS was subsequently replaced with fresh medium at 2 day intervals
until harvest. Permethrin was dissolved in dimethyl sulfoxide (DMSO) prior to addition
to culture medium to achieve various treatment concentrations (0.01, 0.1, 1, & 10 µM).
These concentrations are based on the observation that serum and adipose tissue
concentrations of cypermethrin administered at 2 mg/kg body weight for 10 weeks were
in the range of 2-12 µM, while acceptable daily intake of permethrin is 0.05 mg/kg body
weight (~60 nM) 18, 265. Overall DMSO concentration in culture medium including
control and permethrin treatment groups were 0.02%.
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6.2.3 Measurement of intracellular calcium

Intracellular calcium was determined using Fura-2 acetoxymethyl (AM) ester, a
ratiometric fluorescence Ca2+ indicator, as described previously with slight modifications
343, 344

. Briefly, 3T3-L1 cells were seeded in 96-well plate and induced to differentiation

(day 0). Permethrin treatment was started on day 0 of differentiation until harvest. On day
6, cells were treated with Fura-2-AM- containing 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES)-ringer buffer for 1 h at 37 °C. Then, the HEPESringer buffer was removed and the cells were washed with phosphate-buffered saline
(PBS) twice. The cells were then incubated in PBS for a further 30 minutes to allow
complete de-esterification of intracellular acetoxymethyl esters. The intracellular Ca2+
level were calculated by using excitation at 340 nm and 380 nm and emission at 510 nm
345

.

6.2.4 Western blot analysis

Cell lysates were prepared in radioimmunoprecipitation assay (RIPA) buffer with
ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA)
supplemented with protease inhibitor cocktail and phosphatase inhibitors. Protein
concentrations were determined using BCA protein assay kit. Aliquots from the cell
lysates were separated using 10% SDS-polyacrylamide gel and transferred to an
Immobilin P membrane (Millipore, Bedford, MA). Primary antibodies were purchased
from either Cell Signaling Technologies (Danvers, MA) or Santa Cruz Biotechnologies
(Dallas, TX). Detection were performed using an enhanced chemiluminescence solution
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(GE Healthcare, Piscataway, NJ) with an Image Station 4000MM (Carestream Health,
New Haven, CT). Blot image and results were quantified using Image J software.

6.2.5 Real time PCR analysis

Cells were harvested with Trizol reagent to extract total RNA under RNase free
condition. Then total RNA was reverse transcribed to cDNA using high-capacity reverse
transcription kit (Applied Biosystems, Carlsbad, CA). mRNA level of tumor necrosis
factor alpha (TNFα, Mm00443258_m1), calmodulin (Mm01336281_g1),
calcium/calmodulin dependent protein kinase kinase 2 (CaMKKβ, Mm00520236_m1)
were analyzed by performing Taqman probe-based gene expression analysis (Applied
Biosystems, Carlsbad, CA). 18s rRNA (Mm03928990_g1) was used as an internal
standard.

6.2.6 Statistical analysis

Data were expressed as mean ± S.E. and analyzed with SAS program by one-way
ANOVA with Tukey’s range test (SAS 9.3, Cary, NC). Significance of differences was
defined at the P < 0.05 level.

6.3 Results

6.3.1 Permethrin treatment dose-dependently increased intracellular calcium level
Intracellular calcium, as a ubiquitous second messenger, plays important role in
regulating cellular activities, such as cell growth, proliferation, and apoptosis 346, 347 .
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Recent evidence demonstrated that intracellular calcium signaling is linked with obesity,
adipogenesis and insulin resistance 336-338, 348. Fig 6.1. shows effect of permethrin on
intracellular calcium level in 3T3-L1 adipocytes. Permethrin treatment (0.01, 0.1, 1, & 10
µM) dose-dependently increased intracellular calcium level compared to control in 3T3L1 adipocytes (p < 0.05).

Figure 6.1. Permethrin dose-dependently increased intracellular calcium level in 3T3-L1
adipocytes. 3T3-L1 cells were treated with permethrin (10-12 ~ 10-5M) for 6 days of
differentiation. Intracellular calcium level was measured on day 6 with a fluorescent
calcium indicator fura-2 in acetyoxymethyl form. Numbers are mean ±SE (n=6). Means
with different letters are significantly different (p < 0.05).
6.3.2 Permethrin treatment dose-dependently increased calmodulin (CaM) and
calcium/calmodulin dependent protein kinase kinase 2 (CaMKKβ) in 3T3-L1
adipocytes
Calmodulin is a ubiquitous calcium-binding protein present in all eukaryotic cells
349

. Permethrin treatment (10 µM) significantly increased calmodulin gene expression (p
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= 0.0123) and protein level (p < 0.05) compared to control in 3T3-L1 adipocytes.
CaMKKβ plays a role in calcium/calmodulin-dependent (CaM) kinase cascade and acts
as one of the upstream activators of AMP-activated protein kinase (AMPK) 350. Our
results showed that permethrin (10 µM) increased both gene expression and protein level
of CaMKKβ compared to control in 3T3-L1 adipocytes (p < 0.05).

Figure 6.2. Permethrin dose-dependently increased calmodulin (CaM) and
calcium/calmodulin dependent protein kinase kinase 2 (CaMKKβ) gene expression and
protein level in 3T3-L1 adipocytes. 3T3-L1 cells were treated with permethrin (0.01, 0.1,
1, & 10 µM) for 6 days of differentiation. Cells were harvested on day 6. Gene
expression and protein level of CaM (Fig. 2A & 2C, respectively) and CaMKKβ (Fig. 2B
& 2D, respectively) were shown. Numbers are mean ± SE (n=3-4). Means with different
letters are significantly different (p < 0.05).
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6.3.3 Permethrin treatment significantly increased ER stress
BiP, a molecular chaperone localized in the lumen of ER, binds to misfolded and
newly synthesized proteins and prepares them for subsequent folding, oligomerization or
degradation 339. In addition, Ero1-Lα, an ER membrane-associated N-glycoprotein, is
also involved in protein folding 351. Both BiP and Ero1-Lα are upregulated under ER
stress 339, 351. Our results showed that treatment of permethrin (10 µM) significantly
increased level of BiP and Ero1-Lα (p < 0.05) than control. PERK is an ER
transmembrane protein kinase that phosphorylates the α subunit of translation initiation
factor 2 (eIF2α) at Ser 51 in response to ER stress 259. The phosphorylation status of
PERK and eIF2α is therefore an important marker of the presence of ER stress 259.
Phosphorylation of eIF2α subsequently induces expression of CHOP, which is another
downstream marker of PERK and eIF2α pathway under ER stress 352. Permethrin
treatment (1 & 10 µM) significantly increased phosphorylation of PERK and eIF2α (p <
0.05) as well as protein level of CHOP than control (p < 0.05). Another important ER
stress sensor is inositol-requiring enzyme 1 (IRE1), an ER transmembrane protein that
can undergo phosphorylation to activate the UPR 353, 354. The phosphorylation of IRE1
will lead to splicing of X-box binding protein (XBP1) mRNA into transcription factor
XBP1s, which subsequently increase the synthesis of ER chaperones and phospholipids
339

. Our results showed that permethrin treatment (10 µM) significantly increased

phosphorylation and protein level of IRE1α than control (p < 0.05). In addition, the level
of XBP1s is also significantly increased by permethrin (0.1, 1, & 10 µM) than control (p
< 0.05). Taken together, these results indicated that permethrin treatment significantly
increased ER stress in 3T3-L1 adipocytes.
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Figure 6.3. Permethrin induced ER stress in 3T3-L1 adipocytes. 3T3-L1 cells were
treated with permethrin (0.01, 0.1, 1, & 10 µM) for 6 days of differentiation. Cells were
harvested on day 6 for immunoblotting. Protein expression of binding immunoglobulin
protein (BiP, Fig. 3A); endoplasmic reticulum oxidoreductase 1 alpha (Ero1-Lα, Fig.
3B); phosphorylated RNA-like endoplasmic reticulum kinase (p-PERK, Fig. 3C); PERK
(Fig. 3D); phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2α, Fig. 3E); eIF2α
(Fig. 3F); C/EBP homologous protein (CHOP, Fig. 3G); phosphorylated inositolrequiring enzyme 1 alpha (p-IRE1α, Fig. 3H); IRE1α (Fig. 3I); X-box binding protein 1s
(XBP1s, Fig. 3J) were shown. Numbers are mean ±SE (n=3-4). Means with different
letters are significantly different (p < 0.05).
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6.3.4 Permethrin treatment significantly increased serine phosphorylation of insulin
receptor substrate 1

Phosphorylation of IRS1 at Serine 307 is known to cause insulin resistance 325.
The results showed that permethrin treatment (10 μM) significantly increased p-IRS1
Ser307 (p < 0.05).

Figure 6.4. Permethrin increased serine phosphorylation of insulin receptor substrate 1
(IRS1) in 3T3-L1 adipocytes. 3T3-L1 cells were treated with permethrin (0.01, 0.1, 1, &
10 µM) for 6 days of differentiation. Cells were harvested on day 6 for immunoblotting.
Protein expression of phosphorylated insulin receptor substrate 1 at Serine 307 (p-IRS1
Ser307) were shown. Numbers are mean ±SE (n=3-4). Means with different letters are
significantly different (p < 0.05).
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6.3.5 Permethrin treatment significantly increased gene expression of inflammatory
markers
We further investigated the influence of permethrin treatment on gene expression
of TNFα, one of the key regulators in inflammatory response. All permethrin treatment
(0.01, 0,1, 1, & 10 µM) significantly increased TNFα gene expression level than control.

Figure 6.5. Permethrin increased mRNA expression of tumor neocrosis factor α (TNFα)
in 3T3-L1 adipocytes. 3T3-L1 cells were treated with permethrin (0.01, 0.1, 1, &10 µM)
for 6 days of differentiation and then RNA were extracted using Trizol solution.
Extracted RNA were reverse transcribed to cDNA and then real time PCR (RT-PCR)
were performed. Relative quantities of gene expression with RT-PCR were calculated
relative to 18S ribosomal RNA. Numbers are mean ±SE (n=3). Means with different
letters are significantly different (p < 0.05).
6.4 Discussion
Results from current study suggest that permethrin increased intracellular calcium
and ER stress in 3T3-L1 adipocytes. To our knowledge, this is the first report linking
alteration of calcium and ER stress in 3T3-L1 adipocytes by permethrin treatment.
The current results showed that permethrin dose-dependently increased
intracellular calcium level in 3T3-L1 adipocytes. In fact, pyrethroid insecticides were
known to influence the function of voltage-sensitive calcium channels, resulting in
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increased calcium influx 18, 333, 334. Permethrin and other pyrethroids (e.g., cyfluthrin,
deltamethrin) were potent enhancers of both calcium uptake and neurotransmitter release
via influencing N-type voltage sensitive calcium channels 329, 333. Cismethrin and
deltamethrin were shown to increase intracellular calcium in rat synaptosomes 333.
Deltamethrin were also shown to increase intracellular calcium and ER stress in
neuroblastoma cells 42. As calcium channel α1 subunits is genetically related to the
voltage-sensitive sodium channel 18, it is likely that permethrin may act directly on the
VSSC to increase calcium influx.
Another important intracellular compartment that might contribute to elevated
intracellular calcium level is the ER. ER serves as an important intracellular calcium store
with calcium concentration approximately 1000 times higher than in the cytosol 346. The
calcium concentration in the ER is mainly regulated by three types of proteins: (1) Ca2+
pumps [e.g. sacro/endoplasmic-reticulum Ca2+ -ATPase (SERCA)] for uphill transport of
Ca2+ from the cytosol to the ER lumen; (2) Ca2+ binding proteins [e.g. calsequestrin,
calreticulin, calnexin, 78-kDa glucose-regulated protein/immunoglobulin heavy chain
binding protein (GRP78/BiP), GRP94, and various protein disulfide isomerases (PDI)]
for storage of calcium in the ER and; (3) Ca2+ channels regulating ER calcium release to
cytosol along its electrochemical gradient [(e.g. ryanodine-receptors (RyR) or the inositol
1,4,5,-trisphosphate (IP3)-receptors (IP3R)]

355

.

In normal conditions, the [Ca2+]ER is maintained at a relative stable level to
prevent ER Ca2+ depletion or overload 355. The release of Ca2+ from ER will trigger a
series of cellular responses that lead to an increase of Ca2+ entry into the cytosol of the
cell, a phenomenon known as capacitative calcium entry or “store-operated” Ca2+ entry
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356

. Two key players involved in this process are STIM1 and STIM2 proteins, which are

ubiquitously expressed transmembrane proteins with a luminal Ca2+ sensor 357, 358. The
depletion of ER Ca2+ can lead to the oligomerization of STIM1 or STIM2 and interact
with Orai proteins 358. These tetrameric Ca2+ channels in the plasma membrane are then
responsible for an increased Ca2+ entry 359-361. Recent evidence shows that ER calcium
depletion is also linked with ER stress 355.
In this study, permethrin increased the protein level of Ero1-Lα, an
oxidoreductase enzyme involved in protein folding by catalyzing the formation and
isomerization of protein disulfide bonds in the ER of eukaryotes 362. In addition to its role
in protein folding and oxidation, Ero1-Lα is also involved in regulating ER calcium
release 351. Upregulation of Ero1-Lα leads to loss of ER calcium and hyper-oxidation of
ER lumen, which in turn triggers ER stress 351. In this study, we did not measure calcium
level in the ER. It is likely that permethrin caused ER calcium depletion, which
subsequently lead to store-operated calcium entry from outside of the cell into the cytosol
of the cell.
A large amount of experimental evidence support that ER stress is associated with
obesity, adipogenesis, and insulin resistance 257-259, 341, 342, 363, 364. Three canonical ER
stress pathways have been discovered (Fig. 6.6), which are initiated with three different
ER stress transducers: PERK, IRE1, and activating transcription factor 6 (ATF6). These
transducers are present in the ER membrane and under normal conditions bind to ER
chaperones BiP. Increased binding of BiP to luminal misfolded proteins and its
dissociation from PERK, IRE1, and ATF6, will activate these transducers. PERK
activation will further phosphorylate eIF2α, which slows protein translation and relieve
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ER workload. eIF2α phosphorylation induces expression of CHOP, which is involved in
apoptosis 339. The current results showed that permethrin dose-dependently increased the
phosphorylation of PERK, eIF2α and the protein level of CHOP. These results indicate
that permethrin can cause ER stress by activating PERK pathway. As CHOP is linked
with increased gene expression in inflammatory responses 339. This is consistent with our
results that permethrin treatment significantly increased TNFα level than control.
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Figure 6.6. Potential mechanism of permethrin-potentiated adipogenesis and insulin
resistance in 3T3-L1 adipocytes. Permethrin increases intracellular calcium level and ER
stress pathway evidenced by elevated protein levels of binding immunoglobulin protein
(BIP) and endoplasmic reticulum oxidoreductase 1 alpha (Ero1-Lα). Permethrin also
activates ER stress transducer inositol-requiring enzyme 1 alpha (IRE1α) and protein
kinase R-like endoplasmic reticulum kinase (PERK). IRE1 activation causes activation of
Jun N terminal kinase (JNK) and splicing of X-box binding protein (XBP1) mRNA. The
splicing of XBP1 leads to the translation of transcription factor XBP1s, which upregulate
ER chaperones, endoplasmic reticulum-associated protein degradation (ERAD), lipid
biosynthesis and adipogenesis. Activated PERK will further phosphorylate eukaryotic
translation initiation factor 2 (eIF2α), induces expression of C/EBP homologous protein
(CHOP), which increases inflammatory responses. Permethrin may activate ATF6,
leading to similar results as IRE1α-XBP1s pathway.
IRE1 activation causes splicing of XBP1 mRNA and translation into the
transcription factor XBP1s 339. XBP1s upregulates ER chaperones, components of the
endoplasmic-reticulum-associated protein degradation (ERAD) machinery and
phospholipid biosynthesis 339. The current results indicated that permethrin can activate
the IRE1-XBP1s pathway as indicated by increased phosphorylation of IRE1 and protein
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level of XBP1s. In addition, IRE1 can also activates Jun N terminal kinase (JNK) by
recruiting the scaffold protein tumor necrosis factor receptor-associated factor 2 (TRAF2)
339

. Activated JNK is known to cause insulin resistance via phosphorylation of IRS1

Ser307 365, 366. This is consistent with our finding that permethrin treatment significantly
increased phosphorylation of IRS1 at Ser 307. In addition, recent evidence also
demonstrated that the IRE1α-XBP1s pathway is indispensable for adipogenesis 341.
Currently, we do not have direct evidence that permethrin treatment potentiated
adipogenesis via IRE1α-XBP1s pathway. Future studies using IRE1α- or XBP1- deficient
3T3-L1 adipocytes by permethrin treatment are needed to confirm our hypothesis.
ATF6 is another ER stress transducer present in the ER membrane. ATF6 can also
regulate genes involved in ERAD, lipid biosynthesis, and ER expansion in addition to
IRE1 pathway 339, 367. In this study, we did not measure the markers involved in ATF6
pathway. As it is also an important pathway for lipid biosynthesis, further studies are
needed to investigate whether permethrin influence adipogenesis via ATF6.
In conclusion, our results showed that permethrin may potentiate adipogenesis via
increasing of intracellular calcium level and ER stress. Future studies are needed to
investigate the potential role of permethrin on ER stress in vivo.
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CHAPTER 7
FUTURE DIRECTIONS
Currently, limited knowledge is known about how dietary fat contributed to
permethrin’s effect on weight gain and insulin resistance. The current results showed that
permethrin potentiated weight gain and insulin resistance only in high-fat fed mice.
Considering permethrin is highly lipophilic, it is likely that the absorption and
accumulation of permethrin with high-fat diet would be more efficient than with low-fat
diet. Further investigation on the absorption and accumulation efficacy of permethrin
when delivered orally in low-fat and high-fat diet are needed.
Meanwhile, there is a growing evidence showing that early-life exposure to
insecticides is associated with metabolic disorder later in life 144, 147, 151, 180, 368-370.
Children are more susceptible to chemical exposure because of higher food and water
contamination per kilogram body weight, and higher surface-to-volume ratio 371. In
addition, the metabolic detoxification mechanisms are not fully developed in youth,
which potentially increase the susceptibility to insecticides 372. The current studies are
limited to that adulthood exposure to permethrin can potentiate high-fat diet induced
obesity and type 2 diabetes. Thus, future studies are needed to investigate whether earlylife exposures (e.g. prenatal, neonatal, etc.) can induce metabolic change later in life,
especially when other factors are present, such as diet, as well as sex dependent
responses.
Calcium ions play important role in cellular signaling as well as in adipogenesis
335

. The current results showed that permethrin dose-dependently increased intracellular
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calcium level in 3T3-L1 adipocytes; however, the mechanism how permethrin induces
calcium increase remains unclear. Permethrin could directly act on the voltage sensitive
calcium channel to cause extracellular calcium entry into 3T3-L1 adipocytes followed by
calcium-induced calcium release from ER 373; permethrin could directly cause calcium
release from intracellular calcium storage sites (e.g. ER and/or mitochondria) followed by
store-operated calcium entry from extracellular space 356. Thus, future studies are needed
to determine the route of permethrin-induced calcium mobilization in adipocytes. In
addition, the current results demonstrate that permethrin induced ER stress in 3T3-L1
adipocytes. As elevated intracellular calcium and ER stress are linked with obesity and
type 2 diabetes in vivo 259, 336, we speculate that permethrin, along with high-fat diet,
could promote obesity and type 2 diabetes via calcium- and ER stress- mediated
mechanism in vivo. Future studies are needed to verify our hypothesis.
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